New! View global litigation for patent families

US7064197B1 - System, array and non-porous solid support comprising fixed or immobilized nucleic acids - Google Patents

System, array and non-porous solid support comprising fixed or immobilized nucleic acids Download PDF

Info

Publication number
US7064197B1
US7064197B1 US08486070 US48607095A US7064197B1 US 7064197 B1 US7064197 B1 US 7064197B1 US 08486070 US08486070 US 08486070 US 48607095 A US48607095 A US 48607095A US 7064197 B1 US7064197 B1 US 7064197B1
Authority
US
Grant status
Grant
Patent type
Prior art keywords
non
porous
support
solid
moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US08486070
Inventor
Elazar Rabbani
Jannis G. Stavrianopoulos
Dollie Kirtikar
Kenneth H. Johnston
Barbara E. Thalenfeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enzo Life Sciences Inc
Original Assignee
Enzo Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date
Family has litigation

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the means of detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Nucleic acid analysis involving immobilisation; Immobilisation characterised by the carrier or coupling agent
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/543Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/551Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552Glass or silica
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/80Fluorescent dyes, e.g. rhodamine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81Tube, bottle, or dipstick
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Abstract

Nucleic acids are fixed or immobilized to non-porous solid supports (substrates), and include systems containing such supports and arrays with fixed or immobilized nucleic acids. These compositions are useful for nucleic acid analyses and a host of applications, including, for example, detection, mutational analysis and quantification. The non-porous solid supports can be transparent or translucent, and the surfaces can be treated with agents to fix or immobilize the nucleic acids. Such agents include, for example, amine providing compounds, epoxy compounds and acid solutions. The fixed or immobilized nucleic acids can be unlabeled, or labeled with at least one non-radioactive signaling moiety, such as the case when the nucleic acids are double-stranded.

Description

CROSS-REFERENCE TO OTHER RELATED APPLICATIONS

This is a continuation application of U.S. Patent Application Ser. No. 07/967,646, filed on Oct. 28, 1992, now abandoned, which application is a continuation application of U.S. Patent Application Ser. No. 07/607,347, filed on Oct. 30, 1990, also abandoned. Ser. No. 07/607,347 is a continuation of U.S. Patent Application Ser. No. 07/385,986, filed on Jul. 20, 1989, now U.S. Pat. No. 4,994,373 issued on Feb. 19, 1991. Ser. No. 07/385,986 is a continuation of U.S. Patent Application Ser. No. 06/732,374, filed on May 9, 1985, also abandoned, which application is a continuation-in-part of U.S. Patent Application Ser. No. 06/461,469, filed on Jan. 27, 1983, also abandoned.

TECHNICAL FIELD OF INVENTION

The present invention relates generally to the detection of genetic material by polynucleotide probes. More specifically, it relates to a method for quantifiably detecting a targeted polynucleotide sequence in a sample of biological and/or nonbiological material employing a probe capable of generating a soluble signal. The method and products disclosed herein in accordance with the invention are expected to be adaptable for use in many laboratory, industrial, and medical applications wherein quantifiable and efficient detection of genetic material is desired.

BACKGROUND OF THE INVENTION

In the description, the following terms are employed:

Analyte—A substance or substances, either alone or in admixtures, whose presence is to be detected and, if desired, quantitated. The analyte may be a DNA or RNA molecule of small or high molecular weight, a molecular complex including those molecules, or a biological system containing nucleic acids, such as a virus, a cell, or group of cells. Among the common analytes are nucleic acids (DNA and RNA) or segments thereof, oligonucleotides, either single- or double-stranded, viruses, bacteria, cells in culture, and the like. Bacteria, either whole or fragments thereof, including both gram positive and gram negative bacteria, fungi, algae, and other microorganisms are also analytes, as well as animal (e.g., mammalian) and plant cells and tissues.

Probe—A labelled polynucleotide or oligonucleotide sequence which is complementary to a polynucleotide or oligonucleotide sequence of a particular analyte and which hybridizes to said analyte sequence.

Label—That moiety attached to a polynucleotide or oligonucleotide sequence which comprises a signalling moiety capable of generating a signal for detection of the hybridized probe and analyte. The label may consist only of a signalling moiety, e.g., an enzyme attached directly to the sequence. Alternatively, the label may be a combination of a covalently attached bridging moiety and signalling moiety or a combination of a non-covalently bound bridging moiety and signalling moiety which gives rise to a signal which is detectable, and in some cases quantifiable.

Bridging Moiety—That portion of a label which on covalent attachment or non-covalent binding to a polynucleotide or oligonucleotide sequence acts as a link or a bridge between that sequence and a signalling moiety.

Signalling Moiety—That portion of a label which on covalent attachment or non-covalent binding to a polynucleotide or oligonucleotide sequence or to a bridging moiety attached or bound to that sequence provides a signal for detection of the label.

Signal—That characteristic of a label or signalling moiety that permits it to be detected from sequences that do not carry the label or signalling moiety.

The analysis and detection of minute quantities of substances in biological and non-biological samples has become a routine practice in clinical, diagnostic and analytical laboratories. These detection techniques can be divided into two major classes: (1) those based on ligand-receptor interactions (e.g., immunoassay-based techniques), and (2) those based on nucleic acid hybridization (polynucleotide sequence-based techniques).

Immunoassay-based techniques are characterized by a sequence of steps comprising the non-covalent binding of an antibody and antigen complementary to it. See, for example, T. Chard, An Introduction To Radioimmunoassay And Related Techniques (1978).

Polynucleotide sequence-based detection techniques are characterized by a sequence of steps comprising the non-covalent binding of a labelled polynucleotide sequence or probe to a complementary sequence of the analyte under hybridization conditions in accordance with the Watson-Crick base pairing of adenine (A) and thymine (T), and guanine (G) and cytosine (C), and the detection of that hybridization. [M. Grunstein and D. S. Hogness, “Colony Hybridization: A Method For The Isolation Of Cloned DNAs That Contain A Specific Gene”, Proc. Natl. Acad. Sci. USA, 72, pp. 3961–65 (1975)]. Such polynucleotide detection techniques can involve a fixed analyte [see, e.g., U.S. Pat. No. 4,358,535 to Falkow et al], or can involve detection of an analyte in solution [see U.K. patent application 2,019,408 A].

The primary recognition event of polynucleotide sequence-based detection techniques is the non-covalent binding of a probe to a complementary sequence of an analyte, brought about by a precise molecular alignment and interaction of complementary nucleotides of the probe and analyte. This binding event is energetically favored by the release of non-covalent bonding free energy, e.g., hydrogen bonding, stacking free energy and the like.

In addition to the primary recognition event, it is also necessary to detect when binding takes place between the labelled polynucleotide sequence and the complementary sequence of the analyte. This detection is effected through a signalling step or event. A signalling step or event allows detection in some quantitative or qualitative manner, e.g., a human or instrument detection system, of the occurrence of the primary recognition event.

The primary recognition event and the signalling event of polynucleotide sequence based detection techniques may be coupled either directly or indirectly, proportionately or inversely proportionately. Thus, in such systems as nucleic acid hybridizations with sufficient quantities of radiolabeled probes, the amount of radio-activity is usually directly proportional to the amount of analyte present. Inversely proportional techniques include, for example, competitive immuno-assays, wherein the amount of detected signal decreases with the greater amount of analyte that is present in the sample.

Amplification techniques are also employed for enhancing detection wherein the signalling event is related to the primary recognition event in a ratio greater than 1:1. For example, the signalling component of the assay may be present in a ratio of 10:1 to each recognition component, thereby providing a 10-fold increase in sensitivity.

A wide variety of signalling events may be employed to detect the occurrence of the primary recognition event. The signalling event chosen depends on the particular signal that characterizes the label or signalling moiety of the polynucleotide sequence employed in the primary recognition event. Although the label may only consist of a signalling moiety, which may be detectable, it is more usual for the label to comprise a combination of a bridging moiety covalently or non-covalently bound to the polynucleotide sequence and a signalling moiety that is itself detectable or that becomes detectable after further modification.

The combination of bridging moiety and signalling moiety, described above, may be constructed before attachment or binding to the sequence, or it may be sequentially attached or bound to the sequence. For example, the bridging moiety may be first bound or attached to the sequence and then the signalling moiety combined with that bridging moiety. In addition, several bridging moieties and/or signalling moieties may be employed together in any one combination of bridging moiety and signalling moiety.

Covalent attachment of a signalling moiety or bridging moiety/signalling moiety combination to a sequence is exemplified by the chemical modification of the sequence with labels comprising radioactive moieties, fluorescent moieties or other moieties that themselves provide signals to available detection means or the chemical modification of the sequence with at least one combination of bridging moiety and signalling moiety to provide that signal.

Non-covalent binding of a signalling moiety or bridging moiety/signalling moiety to a sequence involve the non-covalent binding to the sequence of a signalling moiety that itself can be detected by appropriate means, i.e., or enzyme, or the non-covalent binding to the sequence of a bridging moiety/signalling moiety to provide a signal that may be detected by one of those means. For example, the label of the polynucleotide sequence may be a bridging moiety non-covalently bound to an antibody, a fluorescent moiety or another moiety which is detectable by appropriate means. Alternatively, the bridging moiety could be a lectin, to which is bound another moiety that is detectable by appropriate means.

There are a wide variety of signalling moieties and bridging moieties that may be employed in labels for covalent attachment or non-covalent binding to polynucleotide sequences useful as probes in analyte detection systems. They include both a wide variety of radioactive and non-radioactive signalling moieties and a wide variety of non-radioactive bridging moieties. All that is required is that the signalling moiety provide a signal that may be detected by appropriate means and that the bridging moiety, if any, be characterized by the ability to attach covalently or to bind non-covalently to the sequence and also the ability to combine with a signalling moiety.

Radioactive signalling moieties and combinations of various bridging moieties and radioactive signalling moieties are characterized by one or more radioisotopes such as 32P, 131I, 14C, 3H, 60Co, 59Ni, 63Ni and the like. Preferably, the isotope employed emits β or γ radiation and has a long half life. Detection of the radioactive signal is then, most usually, accomplished by means of a radioactivity detector, such as exposure to a film.

The disadvantages of employing a radioactive signalling moiety on a probe for use in the identification of analytes are well known to those skilled in the art and include the precautions and hazards involved in handling radioactive material, the short life span of such material and the correlatively large expenses involved in use of radioactive materials.

Non-radioactive signalling moieties and combinations of bridging moieties and non-radioactive signalling moieties are being increasingly used both in research and clinical settings. Because these signalling and bridging moieties do not involve radioactivity, the techniques and labelled probes using them are safer, cleaner, generally more stable when stored, and consequently cheaper to use. Detection sensitivities of the non-radioactive signalling moieties also are as high or higher than radio-labelling techniques.

Among the presently preferred non-radioactive signalling moieties or combinations of bridging/signalling moieties useful as non-radioactive labels are those based on the biotin/avidin binding system. [P. R. Langer et al., “Enzymatic Synthesis Of Biotin-Labeled Polynucleotides: Novel Nucleic Acid Affinity Probes”, Proc. Natl. Acad. Sci. USA, 78, pp. 6633–37 (1981); J. Stavrianopoulos et al., “Glycosylated DNA Probes For Hybridization/Dection Of Homologous Sequences”, presented at the Third Annual Congress For Recombinant DNA Research (1983); R. H. Singer and D. C. Ward, “Actin Gene Expression Visualized In Chicken Muscle Tissue Culture By Using In Situ Hybridization With A Biotinated Nucleotide Analog”, Proc. Natl. Acad. Sci. USA, 79, pp. 7331–35 (1982)]. For a review of non-radioactive signalling and bridging/signalling systems, both biotin/avidin and otherwise, see D. C. Ward et al., “Modified Nucleotides And Methods Of Preparing And Using Same”, European Patent application No. 63879.

The above-referenced U.S. Patent Application Ser. No. 06/255,223 was abandoned in favor of continuation application, U.S. Patent Application Ser. No. 06/496,915, filed on May 23, 1983, now U.S. Pat. No. 4,711,955. A related divisional application of the aforementioned Ser. No. 06/496,915 was filed (on Dec. 8, 1987) as U.S. Patent Application Ser. No. 07/130,070 and issued on Jul. 12, 1994 as U.S. Pat. No. 5,328,824. Two related continuation applications of the aforementioned Ser. No. 07/130,070 were filed on Feb. 26, 1992 (as Ser. No. 07/841,910) and on May 20, 1992 as (Ser. No. 07/886,660). The aforementioned applications, Ser. No. 07/886,660 and Ser. No. 07/841,910, issued as U.S. Pat. Nos. 5,449,767 and 5,476,928 on Sep. 12, 1995 and Dec. 19, 1995, respectively. The above-referenced U.S. Patent Application Ser. No. 06/391,440, filed on Jun. 23, 1982, was abandoned in favor of U.S. Patent Application Ser. No. 07/140,980, filed on Jan. 5, 1988, the latter now abandoned. Two divisional applications of the aforementioned Ser. No. 07/140,980, U.S. Patent Applications Ser. Nos. 07/532,704 (filed on Jun. 4, 1990 for “Base Moiety Labeled Detectable Nucleotide”) and 07/567,039 (filed on Aug. 13, 1990 for “Saccharide Specific Binding System Labeled Nucleotides”) issued as U.S. Pat. Nos. 5,241,060 (Aug. 31, 1993) and 5,260,433 (Nov. 9, 1993), respectively. The disclosures of the above-identified PNAS article (P. R. Langer et al., “Enzymatic Synthesis of Biotin-Labeled Polynucleotides: Novel Nucleic Acid Affinity Probes,” Proc. Natl. Acad. Sci.(USA) 78:6633–6637 (1981) and U.S. Pat. Nos. 4,711,955, 5,328,824, 5,449,767, 5,476,928, 5,241,060, 5,260,433, and 4,358,535 are herein incorporated and made part of this disclosure.

Generally, the signalling moieties employed in both radioactive and non-radioactive detection techniques involve the use of complex methods for determining the signalling event, and/or supply only an unquantitable positive or negative response. For example, radioactive isotopes must be read by a radioactivity counter; while signalling moieties forming insoluble “signals”, i.e., precipitates, certain fluorescers, and the like [see, e.g., David et al., U.S. Pat. No. 4,376,100] only provide detection not quantitation of the analyte present in the tested sample.

One step toward facilitating rapid and efficient quantitation as well as detection of the hybridization event was the work of Heller et al. in European Patent Applications No. 70685 and 70687 which describe the use of a signalling moiety which produces a soluble signal for measurable detection by a spectrophotometer. These European patent applications disclose the use of two different probes complementary to different portions of a gene sequence, with each probe being labelled at the end which will abut the other probe upon hybridization. The first probe is labelled with a chemiluminescent complex that emits lights of a specific wavelength. The second probe is labelled with a molecule that emits light of a different wavelength measurable by spectrophotometry when excited by the proximity of the first signalling moiety. However, this technique is performed in solution and can generate false positive results in the absence of the analyte if the two probes happen to approach too closely in solution and react with each other.

Similarly, U.K. Patent Application 2,019,408A, published Oct. 31, 1979, discloses a method for detecting nucleic acid sequences in solution by employing an enzyme-labelled RNA or DNA probe which, upon contact with a chromogen substrate, provides an optically readable signal. The analytes may be separated from contaminants prior to hybridization with the probe, or, alternatively, the hybrid probe-analyte may be removed from solution by conventional means, i.e., centrifugation, molecular weight exclusion, and the like. Like Heller's technique, this method is performed in solution.

There remains therefore a need in the art for a reliable, simple and quantifiable technique for the detection of analytes of interest in biological and non-biological samples.

SUMMARY OF THE INVENTION

The invention provides a solution for the disadvantages of presently available methods of detecting analytes by a novel combination of hybridization and immunological techniques. In the present invention, chemically labelled polynucleotide or oligonucleotide probes are employed to detect analytes by having the capacity to generate a reliable, easily quantifiable soluble signal.

Analytes to be detected by the detection processes of this invention may be present in any biological or non-biological sample, such as clinical samples, for example, blood urine, feces, saliva, pus, semen, serum, other tissue samples, fermentation broths, culture media, and the like. If necessary, the analyte may be pre-extracted or purified by known methods to concentrate its nucleic acids. Such nucleic acid concentration procedures include, for example, phenol extraction, treatment with chloroform-isoamyl alcohol or chloroform-octanol, column chromatography (e.g., Sephadex, hydroxyl apatite), and CsCl equilibrium centrifugation. The analyte, separated from contaminating materials, if present, is according to the present invention, fixed in hybridizable form to a solid support.

Analytes in a biological sample are preferably denatured into single-stranded form, and then directly fixed to a suitable solid support. Alternatively, the analyte may be directly fixed to the support in double-stranded form, and then denatured. The present invention also encompasses indirect fixation of the analyte, such as in in situ techniques where the cell is fixed to the support and sandwich hybridization techniques where the analyte is hybridized to a polynucleotide sequence that is fixed to the solid support. It is preferred that the solid support to which the analyte is fixed be non-porous and transparent, such as glass, or alternatively, plastic, polystyrene, polyethylene, dextran, polypropylene and the like. Conventional porous materials, e.g., nitrocellulose filters, although less desirable for practice of the method of the present invention, may also be employed as a support.

It is also highly desirable that the analyte be easily fixed to the solid support. The capability to easily fix the analyte to a transparent substrate would permit rapid testing of numerous samples by the detection techniques described herein.

Chemically-labeled probes are then brought into contact with the fixed single-stranded analytes under hybridizing conditions. The probe is characterized by having covalently attached to it a chemical label which consists of a signalling moiety capable of generating a soluble signal. Desirably, the polynucleotide or oligonucleotide probe provides sufficient number of nucleotides in its sequence, e.g., at least about 25, to allow stable hybridization with the complementary nucleotides of the analyte. The hybridization of the probe to the single-stranded analyte with the resulting formation of a double-stranded or duplex hybrid is then detectable by means of the signalling moiety of the chemical label which is attached to the probe portion of the resulting hybrid. Generation of the soluble signal provides simple and rapid visual detection of the presence of the analyte and also provides a quantifiable report of the relative amount of analyte present, as measured by a spectrophotometer or the like.

The method of the present invention involving the colorimetric or photometric determination of the hybridized probes employs as the signalling moiety reagents which are capable of generating a soluble signal, e.g., a color change in a substrate in solution. Preferable components of the signalling moiety include enzymes, chelating agents and co-enzymes, which are able to generate colored or fluorescent soluble signals. Specifically, certain chromogens upon contact with certain enzymes are utilizable in the method of the present invention. The following Table I lists exemplary components for the signalling moiety of the present invention. Each chromogen listed is reactive with the corresponding enzyme to produce a soluble signal which reports the presence of the chemically-labeled probe analyte hybrid. The superscript notation (*) indicates that the chromogen fluoresces, rather than produces a color change.

TABLE I
ENZYME CHROMOGEN
alkaline phosphatase *4-Methylumbelliferyl
or phosphate
acid phosphatase *bis (4-Methylumbelli-
feryl phosphate
3-0-methylfluorescein.
*Flavone-3-diphosphate
triammonium salt
p-nitrophenyl phosphate
2Na.
peroxidase *Tyramine hydro-
chloride
*3-(p-hydroxyphenyl)
Propionic acid
*p-Hydroxyphenethyl
alcohol
2,2′-Azino-Di-3-
Ethylbenzthiazoline
sulfonic acid
(ABTS)
ortho-phenylenedia-
mine 2HCl
0-dianisidine
*5-aminosalicylic acid
p-cresol
3,3′-dimethyloxy-
benzidine
3-methyl-2-benzo-
thiazoline hydra-
zone
tetramethyl benzidine
β-D-galactosidase 0-nitrophenyl β-D-
galactopyranoside
4-methylumbelliferyl-
β-D-galactoside
glucose-oxidase ABTS

As another aspect of the present invention, the signalling moiety may be attached to the probe through the formation of a bridging entity or complex. Likely candidates for such a bridging entity would include a biotin-avidin bridge, a biotin-streptavidin bridge, or a sugar-lectin bridge.

Once the fixed probe-analyte hybrid is formed, the method may further involve washing to separate any non-hybridized probes from the area of the support. The signalling moiety may also be attached to the probe through the bridging moiety after the washing step to preserve the materials employed. Thereafter, another washing step may be employed to separate free signalling moieties from those attached to the probe through the bridging moiety.

Broadly, the invention provides hybridization techniques which provide the same benefits as enzyme linked immunosorbent assay techniques, i.e, the qualitative and quantitative determination of hybrid formation through a soluble signal. Various techniques, depending upon the chemical label and signalling moiety of the probe, may be employed to detect the formation of the probe-analyte hybrid. It is preferred, however, to employ spectrophotometric techniques and/or colorimetric techniques for the determination of the hybrid. These techniques permit not only a prompt visual manifestation of the soluble signal generated by the signalling moiety on the double-stranded hybrid, but also permit the quantitative determination thereof, i.e., by the enzymatic generation of a soluble signal that can be quantitatively measured.

Yet another aspect of the method of the present invention involves generating the soluble signal from the probe-analyte hybrid in a device capable of transmitting light therethrough for the detection of the signal by spectrophotometric techniques. Examples of devices useful in the spectrophotometric analysis of the signal include conventional apparatus employed in diagnostic laboratories, i.e., plastic or glass wells, tubes, cuvettes or arrangements of wells, tubes or cuvettes. It may also be desirable for both the solid support to which the analyte is fixed and the device to be composed of the same material, or for the device to function as the support in addition to facilitating spectrophotometric detection.

A further aspect of the present invention provides products useful in the disclosed method for detection of a polynucleotide sequence. Among these products is a device containing a portion for retaining a fluid. Such portion contains an immobilized polynucleotide sequence hybridized to a polynucleotide or oligonucleotide probe. The probe, as described above, has covalently attached thereto a chemical label including a signalling moiety capable of generating a soluble signal. Also part of the device is a soluble signal, preferably a colored or fluorescent product, generatable by means of the signalling moiety. The portion of the device for containing the fluid is desirably a well, a tube, or a cuvette. A related product of the invention is an apparatus comprising a plurality of such devices for containing a fluid, in which at least one such device contains the above-described immobilized polynucleotide sequence, polynucleotide or oligonucleotide probe, signalling moiety, and soluble signal. Additionally the present invention provides for the novel product of a non-porous solid support to which a polynucleotide is directly fixed in hybridizable form. Such a fixed sequence may be hybridized to another polynucleotide sequence having covalently attached thereto a chemical label including a signalling moiety capable of generating a soluble signal. As indicated above, the support is preferably transparent or translucent. Such products could be advantageously employed in diagnostic kits and the like.

Other aspects and advantages of the present invention will be readily apparent upon consideration of the following detailed description of the preferred embodiments thereof.

DETAILED DESCRIPTION

The following examples are illustrative of preferred embodiments of the method of the present invention. Specifically referred to therein are methods for fixing the analyte to a non-porous solid support, as well as illustrations of the use of soluble signals in polynucleotide probes as discussed above.

EXAMPLE 1

For purposes of the present invention, an analyte is immobilized on a solid support, preferably a non-porous translucent or transparent support. To effect easy fixing of a denatured single-stranded DNA sequence to a glass support, an exemplary “fixing” procedure may involve pretreating the glass by heating or boiling for a sufficient period of time in the presence of dilute aqueous nitric acid. Approximately forty-five minutes in 5% dilute acid should be adequate to leach boron residues from a borosilicate glass surface. The treated glass is then washed or rinsed, preferably with distilled water, and dried at a temperature of about 115° C., for about 24 hours. A 10 percent solution of gamma-aminopropyltriethoxysilane, which may be prepared by dissolving the above-identified silane in distilled water followed by addition of 6N hydrochloric acid to a pH of about 3.45, will then be applied to the glass surface. The glass surface is then incubated in contact with the above-identified silane solution for about 2–3 hours at a temperature of about 45° C. The glass surface is then washed with an equal volume of water and dried overnight at a temperature of about 100° C. The resulting treated glass surface will now have available alkylamine thereon suitable for immobilizing or fixing any negatively charged polyelectrolytes applied thereto. [See Weetal, H. H. and Filbert, A. M., “Porous Glass for Affinity Chromatography Applications”, Methods in Enzymology, Vol. XXXIV, Affinity Techniques Enzyme Purification: Part B. pp. 59–72, W. B. Jakoby and M. Wilchek, eds.]

Such treated glass could then be employed in the method of the invention. For example, glass plates provided with an array of depressions or wells would have samples of the various denatured analytes deposited therein, the single-stranded analytes being fixed to the surfaces of the wells. Thereupon, polynucleotide probes provided with a chemical label may be deposited in each of the wells for hybridization to any complementary single-stranded analyte therein. After washing to remove any non-hybridized probe, the presence of any hybrid probe-analyte is detectable One then detection - - - technique as described herein involves the addition of an enzyme-linked antibody or other suitable bridging entity of the label for attachment to the probe. Subsequently a suitable substrate is added to elicit the soluble signal, e.g., a color change or chemical reaction, which is then measured colorimetrically or photometrically.

This invention also provides an apparatus comprising a plurality of means for containing a fluid, wherein at least one of the means comprises (i) an immobilized polynucleotide sequence hybridized to a polynucleotide or oligonucleotide probe, the probe having covalently attached thereto, a chemical label comprising a signalling moiety capable of forming a soluble signal, and (ii) a soluble signal generated by means of the signalling moiety.

Also provided by this invention is a non-porous solid support having directly fixed thereto a polynucleotide sequence in hybridizable form. Such a support is characterized in that the polynucleotide sequence is hybridized to a polynucleotide or oligonucleotide probe, the probe having covalently attached thereto a chemical label comprising a signalling moiety capable of generating a soluble signal. Such a support is also characterized in that the support is a transparent or translucent support.

EXAMPLE 2

A glass surface treated as described in Example 1 can be employed in the method of the present invention, wherein glucosylated DNA is employed as the labelled probe, and the signalling moiety comprises the combination of acid phosphatase and its substrate paranitrophenylphosphate.

In this procedure, glucosylated bacteriophage T4 DNA, isolated from E. coli CR63 cultures infected with phage T4 AM82 [4462] and purified to be free of chromosomal DNA, or non-glucosylated, highly purified calf thymus DNA is delivered in 100 μl portions to treated glass tubes in triplicate set. After 15–30 minutes at room temperature, the solution is removed and the tubes rinsed generously with PBS·Mg++ buffer [100 mM Na—K—PO4, pH 6.5, 150 mM NaCl and 10 mM MgCl2].

One set of tubes is checked for the presence of DNA by staining with ethidium bromide [100 μl of 1 mg/ml solution, 30 minutes in the dark, at room temperature]. The staining solution is removed and the tubes rinsed and checked by UV light. Both glucosylated labelled and unlabelled DNA “probe” bound to the activated glass surface by the observed red fluorescence characteristic of ethidium bromide.

To another set of tubes is delivered fluorescein-labelled ConA [100 μl of 0.1 mg/ml in PBS·Mg++ buffer]. The Concanavalin A [ConA] is obtained and solubilized in 2.0 M NaCl at a concentration of 50 mg/ml, and fluorescein-labelled by reacting ConA with fluorescein isothiocyanate at an FITC to protein molar ratio of 3 to 1 in 0.1 M sodium borate solution at a pH of 9.2 and at a temperature of 37° C. for 60 minutes. Any unreacted FITC is removed by gel filtration on Sephadex G-50. After 60 minutes at room temperature, the solution is removed and the tubes rinsed and checked under UV light. ConA bound only to glucosylated DNA in tubes containing T4 DNA.

To the third set of tubes is delivered 100 μl of unlabeled ConA in PBS·Mg++ buffer. After 60 minutes at room temperature, the tubes are rinsed free of ConA with 0.2 M Imidazole buffer pH 6.5.

Acid phosphatase is then added [0.005 units in 100 μl at 0.2 percent phosphatase-free BSA] and the tubes are incubated at room temperature for 30 minutes. After rinsing with 0.15 M NaCl to remove any unbound enzyme, 0.1 mM paranitrophenylphosphate in 0.2 M imidazole at pH 6.5 is added and incubation continued for 60 minutes at 37° C. The enzyme reaction is terminated by adding 1.0 ml of 0.5 percent sodium bicarbonate and absorbance is determined at A300.

The resulting observed test results indicate that acid phosphatase, one component of the signalling moiety gives a positive visible color reaction, upon reaction with its chromogen, only in tubes containing “probe” T4 DNA and bridging moiety, ConA, but is washed off from the tubes which contain only ConA or ConA and calf thymus DNA.

EXAMPLE 3

In an example of the method of the present invention, phage lambda DNA was employed as the analyte, glucosylated DNA as the labelled probe, ConA as the bridging entity and alkaline phosphatase with paranitrophenylphosphate as the signalling moiety. Bacteriophage lambda, obtained by heat induction of E. coli stain W3350 lysogenic for γC1 857 phage, was employed for the preparation of phage lambda DNA. In these tests, the analyte, phage lambda DNA, was immobilized on an activated glass surface according to the following procedure. After rinsing with buffer, glass tubes were coated with 100 μl of coating solution [50 percent formamide, 5X SSC, 100 μg salmon sperm DNA 0.2 percent polyvinyl pyrrolidone, 0.1 percent Triton X-100, 0.2 percent BSA and 0.05 percent SDS] at 42° C. for 90–120 minutes. The coating solution was removed and the surface was covered with 100 μl of coating solution containing phage lambda DNA.

Phage lamba DNA employed as the probe is nick translated with maltose-triose dUTP to introduce glucosyl residues into the DNA. The glucosylated minutes and rapidly cooled in ice bath immediately before use. The tubes were then incubated with probe at 42° C. for 24 hours. The solution was removed and tubes were rinsed with PBS·Mg++ buffer. As described above in example 2, ConA is added to the tubes in PBS·Mg buffer. After 60 minutes at room temperature the tubes are rinsed with 0.2 M Imidazole buffer.

Also as described in Example 2, the signalling moiety components, acid phosphatase and paranitrophenyl phosphate, are sequentially introduced into the tubes, to generate the detectable soluble signal. In these tests, the glucosyl moiety of the DNA probe is one bridging moiety of the chemical label, and reacts with and is strongly attracted to the second bridging moiety, ConA. The results indicated that acid phosphatase was not washed off from the tubes which contained glucosylated probe, whereas tubes containing non-labelled probe did not show any enzyme activity.

EXAMPLE 4

As in the above example employing a glucosylated DNA as the labelled probe, wherein the glucosyl moiety serves as part of the chemical label, comparable results may also be achieved by employing a biotin-labeled DNA probe. When biotin is employed as a bridging moiety of the chemical label of the DNA probe, the presence of the biotin-labeled DNA probe would be elicited or detected by means of an avidin or streptavidin-linked enzyme, since avidin is strongly reactive with or strongly bonds to biotin.

For example, a biotin-labeled DNA probe would readily be detected by an enzyme complex of the character avidin-biotin-alkaline phosphatase. More specifically, the presence of the biotin-labeled DNA probe would readily be detected by contacting the hybrid containing the biotin-labeled probe with the enzyme complex avidin-biotin-alkaline phosphatase, and bringing the resulting probe and avidin-biotin-alkaline phosphatase complex into contact with a suitable substrate which, upon contact with the enzyme, would produce a soluble signal that would be readily noticed or be capable of being determined, both qualitatively and quantitatively, by photometric and/or colorimetric means. If desired, instead of an avidin-biotin-enzyme complex, there could be used an antibody to biotin for attachment to the biotin moiety of the biotin-labeled DNA probe, followed by a complex comprising anti-antibody-enzyme in the manner described above.

EXAMPLE 5

The advantages of this invention are also obtainable when the probe is immobilized on a non-porous plastic surface. When a plastic surface is employed, it is sometimes desirable to increase the effectiveness or uniformity of the fixation by pretreating the plastic surface.

Because polystyrene from various batches or sources exhibits different binding capacities, the adherence or fixing of DNA to a polystyrene surface is improved by treating the surface with an amino-substituted hydrophobic polymer or material. Previous experiments demonstrated that addition of duodecadiamine (DDA) to polystyrene resulted in an uniform binding coefficient of polystyrene plates of different batches. Another technique for improving the fixing or uniformity of the plastic surface for fixing DNA involves treatment of the surface with polylysine (PPL).

In tests involving the fixing of DNA to a plastic surface, biotinylated DNA (b-DNA) was denatured and aliquoted into Dynatech, Immulon II™ removable wells. Samples were allowed to dry onto the plastic surface at 37° C. The amount of bound b-DNA was determined by sequential addition of goat anti-biotin antibody and rabbit anti-goat antibody complexed to the signalling moiety, alkaline phosphatase, followed by development with p-nitrophenyl phosphate in diethanolamine buffer, pH 9.6. Enzymatic activity was monitored at 405 nm utilizing the automatic Dynatech Micro ELISA Scanner. This procedure enables quantitation of the amount of bound DNA and therefore the degree of biotinylation. To increase the sensitivity of detection, a fluorogenic substrate such as 4-methylumbelliferyl-phosphate, or its analogues, with companion enzymes, may be used.

In a further example of the method, denatured adenovirus 2 DNA, the analyte, was bound to polystyrene plates as described above. After blocking with Denhardt's formamide blocking buffer, several biotinylated probes, b-adeno-2-DNA and lambda DNA were hybridized to the immobilized DNA. To one set of immobilized DNA, no probe was added. The extent of hybridization was determined by means of the antibody-enzyme reaction as described above. It was observed that only the homologous adeno-2 probe hybridized. This technique demonstrated that in vitro hybridization under these conditions is specific and can be monitored quantitatively by the method of the present invention.

Other methods for enabling fixation of single-stranded analyte to a solid support for use in the method of the present invention include the following.

EXAMPLE 6

In further tests, radioactively-labeled DNA was prepared by nick translation with [3H]dATP. The labelled, non-biotinylated denatured DNA [2000 ng to 5 ng] was applied to DDA-coated polystyrene plates. The test samples or plates were not allowed to dry. After incubation at 37° C. for periods of 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, and 18 hours, samples were counted. Binding was maximal after two hours of incubation, however, 50 percent of the originally applied DNA bound regardless of the concentration, thereby indicating that there is an equilibrium between bound and unbound DNA.

In other tests, polystyrene microfilter wells were nitrated using the procedure of Filipsson and Hornby, Biochem. J. 120, 215 (1970). The polystyrene wells were immersed for 20 minutes in a mixture of concentrated nitric and sulfuric acid [41 percent, v/v] cooled to 0° C. The wells were then washed thoroughly with water and subsequently heated to 70° C. in a 6 percent solution of sodium dithionate in 2 M potassium hydroxide. After 4 hours, the wells were washed thoroughly with 0.5 M hydrochloric acid and distilled water.

To produce 6-aminohexane linked polystyrene, 6-amino-caproic acid-N-hydroxysuccinimide ester·hydrobromide [5 mg thereof dissolved in 0.2 M dimethylformamide prepared by reacting 6-aminocaproic acid·hydrobromide with N-hydroxysuccinimide and dicyclohexyl carbodiimide in dimethylformamide and recrystallized from isopropylalcohol] was added to 0.1 M sodium borate [0.4 ml]. Amino-derivitized polystyrene microfilter wells filled with this solution were allowed to react at room temperature for 4 hours and then washed thoroughly with distilled water. The resulting treated wells absorbed H-labeled DNA from aqueous solution at pH less than 9.5.

An improved capability for fixing or immobilization of DNA to non-porous siliceous solid supports, such as glass and plastic, is also provided by treatment with a coating of an epoxy resin. For example, treatment of glass or polystyrene surfaces with commercially available epoxy glues, such as a solution of epoxy glue in ethanol [1 percent w/v] serves this purpose. These epoxy solutions are applied to the surfaces or wells, and the solvent, ethanol, evaporated thereupon at a temperature of 37° C., thereby providing a polyamine polymeric coating on the treated surface. These surfaces were found to absorb 3H-labeled DNA from aqueous solution at pH less than 9.5.

EXAMPLE 7

Yet another example of the method of the present invention, including fixing the polynucleotide analyte sequence directly to a non-porous solid support, such as a conventional microtiter well, may be performed according to the procedures outlined below.

Conventional microtiter well plates can be pre-rinsed with 1 M ammonium acetate (NH4OAc), in an amount of 200 μls/well. Analyte DNA would be diluted to 10–200 ng/50 ul in water or 10 mM Tris-HCl at pH 7.5 and 1 mM EDTA(TE). After boiling for 5 minutes and quick cooling in ice water, an equal volume of 2M NH4OAc would be added and 50 ul of analyte DNA is added per well, giving 5–100 ng of analyte DNA per well. After open plate incubation for 2 hours at 37° C., the wells can be sealed and plates stored at 4° C. Alternatively, open plates can be incubated at 37° C. until the wells are dry, at which point the plates can be sealed, and stored at 4° C. for up to one-two months. Single-stranded analyte DNA is now fixed to the wells.

An alternative method to denature and then fix the analyte DNA to the well is to add 50 ul of DNA in TE to wells at a concentration of 10–200 ng/50 ul. After adding 25 ul at 0.9 N NaOH and mixing, the plates can be incubated for 10 minutes at room temperature. After adding 25ul of 4 M NH4OAc, the open plate may be incubated at 37° C. for 4 hours or until dry and the plates sealed and stored at 4° C. until ready to use.

To prepare the plates for hybridization, the wells would be rinsed twice with 0.3 m NaCl, 0.03 m sodium citrate (2X SSC) (200 ul/well) buffer regardless of whether the plate was dried or not. Preferably, the wells can be rinsed once with 2X SSC/1% Triton X-100 after the two 2X SSC rinses. Plates should be blotted on absorbent paper before beginning each rinse.

To hybridize the fixed analyte with a probe, the following protocol would be followed. A nick translated probe would be heat denatured and added to a hybridization solution containing 30% formamide (deionized), 2X–4X SSPE (20X SSPE=3.6 M NaCl, 0.2 M NaPO4, pH 7.4, 0.02 M EDTA) depending on the GC content of probe, 0.1% SDS, and 5.0% dextran sulfate to give a final concentration of 0.2–1.0 ug probe/ml. An alternative hybridization solution contains 30% formamide (deionized), 2X–4X SSPE, 1.0% Triton X-100, and 5.0% dextran sulfate and 0.2–1.0 ug probe/ml. 100 ul of the selected hybridization mixture is added to each well. After sealing the plates, they are incubated at 37° C. for a desired time.

The hybridization solution is poured out, or collected by aspiration for reuse if desired. The plates are rinsed twice with 2X SSC and 0.1% SDS or 2X SSC and 0.10% Triton X-100 according to whether the first or second hybridization solution identified above was employed. At this point two to four stringency rinses of SSC and detergent are preferably performed by heating the buffer to the desired temperature and adding it hot to the wells. Formamide and low SSC or SSPE can be used at 37–40° C. to achieve the desired stringency. Following stringency washes, wells are rinsed twice with 1X SSC or 1X SSC and 0.1% Triton X-100, and the plates are now ready for detection.

Detection of the fixed hybridized analyte-probe according to the invention may employ the procedure for commercially available ELISA assays using the sensitive DETEK® 1-alkaline phosphatase or DETEK® 1-horseradish peroxidase assays (Enzo Biochem, Inc.). Beginning at the blocking procedure, the standard method is employed except that after blocking, no rinsing step is used. Complex diluted in 1X complex dilution buffer is thereafter added as taught in these commercially available assays.

As will be apparent to those skilled in the art in the light of the foregoing disclosure, many alterations, modifications and substitutions are possible in the practice of this invention, without departing from the spirit or scope thereof. Consequently, only such limitations as appear in the appended claims should be placed upon the scope of the invention.

Claims (238)

1. A non-porous solid support comprising one or more amine(s), hydroxyl(s) or epoxide(s) thereon, wherein at least one single-stranded nucleic acid is fixed or immobilized in hybridizable form to said non-porous solid support via said one or more amine(s), hydroxyl(s) or epoxide(s).
2. A non-porous solid support comprising one or more amine(s), hydroxyl(s) or epoxide(s) thereon, wherein at least one double-stranded nucleic acid is fixed or immobilized to said non-porous solid support via said one or more amine(s), hydroxyl(s) or epoxide(s), and wherein one nucleic acid strand of said at least one double-stranded nucleic acid has covalently attached thereto either:
(i) a non-radioactive signaling moiety, or
(ii) a non-radioactive bridging moiety covalently or non-covalently attached to a non-radioactive signaling moiety.
3. A non-porous solid support comprising at least one double-stranded nucleic acid fixed or immobilized thereto, wherein one nucleic acid strand of said at least one double-stranded nucleic acid has covalently attached thereto either:
(i) a non-radioactive signaling moiety, or
(ii) a non-radioactive bridging moiety covalently or non-covalently attached to a non-radioactive signaling moiety,
and wherein said fixation or immobilization is not to a cell fixed in situ to said non-porous solid support.
4. A non-porous solid support comprising one or more amine(s), hydroxyl(s) or epoxide(s) thereon, and at least one nucleic acid strand or sequence fixed or immobilized to said non-porous solid support via said one or more amine(s), hydroxyl(s) or epoxide(s), and wherein another nucleic acid strand or sequence is hybridized to said at least one nucleic acid strand or sequence, said another nucleic acid strand or sequence having covalently attached thereto either:
(l) a non-radioactive signaling moiety, or
(ll) a non-radioactive bridging moiety covalently or non-covalently attached to a non-radioactive signaling moiety.
5. A non-porous solid support comprising at least one nucleic acid strand or sequence fixed or immobilized to said non-porous solid support, and wherein one other nucleic acid strand or sequence is hybridized to said at least one nucleic acid strand or sequence, said other nucleic acid strand or sequence having covalently attached thereto either:
(i) a non-radioactive signaling moiety, or
(ii) a non-radioactive bridging moiety covalently or non-covalently attached to a non-radioactive signaling moiety,
and wherein said fixation or immobilization is not to a cell fixed in situ to said non-porous solid support.
6. A system comprising a non-porous solid support which comprises one or more amine(s), hydroxyl(s) or epoxide(s) thereon, wherein at least one single-stranded nucleic acid is fixed or immobilized thereto in hybridizable form to said non-porous solid support via said one or more amine(s), hydroxyl(s) or epoxide(s).
7. A system comprising a non-porous solid support which comprises one or more amine(s), hydroxyl(s) or epoxide(s) thereon, wherein at least one double-stranded nucleic acid is fixed or immobilized to said non-porous solid support via said one or more amine(s), hydroxyl(s) or epoxide(s), and wherein one nucleic acid strand of said double-stranded nucleic acid has covalently attached thereto either:
(l) a non-radioactive signaling moiety, or
(ii) a non-radioactive bridging moiety covalently or non-covalently attached to a non-radioactive signaling moiety.
8. A system comprising a non-porous solid support which comprises one or more amine(s), hydroxyl(s) or epoxide(s) thereon, wherein DNA or RNA is fixed or immobilized in hybridizable form to said non-porous solid support via said one or more amine(s), hydroxyl(s) or epoxide(s).
9. A system comprising a non-porous solid support which comprises one or more amine(s), hydroxyl(s) or epoxide(s) thereon, wherein nucleic acid is fixed or immobilized in hybridizable form to said non-porous solid support via said one or more amine(s), hydroxyl(s) or epoxide(s).
10. A system comprising a non-porous solid support which comprises double-stranded nucleic acid fixed or immobilized thereto, wherein one nucleic acid strand of said double-stranded nucleic acid has covalently attached thereto either:
(i) a non-radioactive signaling moiety, or
(ii) a non-radioactive bridging moiety covalently or non-covalently attached to a non-radioactive signaling moiety,
and wherein said fixation or immobilization is not to a cell fixed in situ to said non-porous solid support.
11. A system comprising a non-porous solid support which comprises a double-stranded nucleic acid fixed or immobilized thereto, wherein one nucleic acid strand of said double-stranded nucleic acid has covalently attached thereto either:
(i) a non-radioactive signaling moiety, or
(ii) a non-radioactive bridging moiety covalently or non-covalently attached to a non-radioactive signaling moiety,
and wherein said fixation or immobilization is not to a cell fixed in situ to said non-porous solid support.
12. A non-porous solid support comprising one or more amine(s), hydroxyl(s) or epoxide(s) thereon, wherein single-stranded nucleic acid is fixed or immobilized in hybridizable form to said non-porous solid support via said one or more amine(s), hydroxyl(s) or epoxide(s).
13. A non-porous solid support comprising one or more amine(s), hydroxyl(s) or epoxide(s) thereon, wherein a single-stranded nucleic acid is fixed or immobilized in hybridizable form to said non-porous solid support via said one or more amine(s), hydroxyl(s) or epoxide(s).
14. A non-porous solid support comprising one or more amine(s), hydroxyl(s) or epoxide(s) thereon, wherein nucleic acid is fixed or immobilized in hybridizable form to said non-porous solid support via said one or more amine(s), hydroxyl(s) or epoxide(s).
15. A non-porous solid support comprising one or more amine(s), hydroxyl(s) or epoxide(s) thereon, wherein DNA or RNA is fixed or immobilized in hybridizable form to said non-porous solid support via said one or more amine(s), hydroxyl(s).
16. The non-porous solid support of claims 1, 2, 12, 13, 14, 15 or 4, wherein said fixation or immobilization is not to a cell fixed in situ to said non-porous solid support.
17. An array comprising various single-stranded nucleic acids fixed or immobilized in hybridizable form to a non-porous solid support.
18. An array comprising various double-stranded nucleic acids fixed or immobilized to a non-porous solid support, wherein at least one nucleic acid strand of said various double-stranded nucleic acids comprises at least one non-radioactive signaling moiety which is quantifiable or detectable.
19. An array comprising single-stranded nucleic acids fixed or immobilized in hybridizable form to a non-porous solid support.
20. An array comprising double-stranded nucleic acids fixed or immobilized to a non-porous solid support, wherein at least one nucleic acid strand of said double-stranded nucleic acids comprises at least one non-radioactive signaling moiety which is quantifiable or detectable.
21. An array comprising various nucleic acids, wherein single-stranded nucleic acids or sequences are fixed or immobilized to a non-porous solid support, and other single-stranded nucleic acids or sequences are hybridized to said fixed or immobilized single-stranded nucleic acids or sequences, said other nucleic acid strands or sequences comprising at least one non-radioactive signaling moiety which is quantifiable or detectable.
22. An array comprising various first single-stranded nucleic acids fixed or immobilized to a non-porous solid support, and further comprising second nucleic acids hybridized to said fixed or immobilized first nucleic acids, wherein said second nucleic acids comprise at least one non-radioactive signalling moiety which is quantifiable or detectable.
23. The non-porous solid support of claims 1, 2, 12, 13, 14, 15, 3, 4 or 5, wherein said non-porous solid support comprises an arrangement of wells, tubes or cuvettes.
24. The non-porous solid support of claim 3 or 5, comprising one or more amines.
25. An array comprising various single-stranded nucleic acids fixed or immobilized in hybridizable form to a non-porous solid support having wells or depressions.
26. An array comprising various double-stranded nucleic acids fixed or immobilized to a non-porous solid support having wells or depressions, wherein at least one nucleic acid strand of each of said various double-stranded nucleic acids comprises at least one non-radioactive signaling moiety which is quantifiable or detectable.
27. A non-porous glass or non-porous plastic solid support comprising one or more amine(s), hydroxyl(s) or epoxide(s) thereon, wherein at least one single-stranded nucleic acid is fixed or immobilized in hybridizable form to said non-porous solid support via said one or more amine(s), hydroxyl(s) or epoxide(s).
28. A non-porous glass or non-porous plastic solid support comprising one or more amine(s), hydroxyl(s) or epoxide(s) thereon, wherein at least one double-stranded nucleic acid is fixed or immobilized to said non-porous glass or non-porous plastic solid support via said one or more amine(s), hydroxyl(s) or epoxide(s), and wherein one nucleic acid strand of said double-stranded nucleic acid has covalently attached thereto either:
(i) a non-radioactive signaling moiety, or
(ii) a non-radioactive bridging moiety covalently or non-covalently attached to a non-radioactive signaling moiety.
29. A non-porous solid support comprising double-stranded nucleic acid fixed or immobilized thereto, wherein one nucleic acid strand of said double-stranded nucleic acid has covalently attached thereto either:
(i) a non-radioactive signaling moiety, or
(ii) a non-radioactive bridging moiety covalently or non-covalently attached to a non-radioactive signaling moiety,
wherein said fixation or immobilization is not to a cell fixed in situ to said non-porous solid support.
30. A non-porous solid support comprising a double-stranded nucleic acid fixed or immobilized thereto, wherein one nucleic acid strand of said double-stranded nucleic acid has covalently attached thereto either:
(i) a non-radioactive signaling moiety, or
(ii) a non-radioactive bridging moiety covalently or non-covalently attached to a non-radioactive signaling moiety,
wherein said fixation or immobilization is not to a cell fixed in situ to said non-porous solid support.
31. The non-porous solid support of claim 1, wherein said nucleic acid comprises a nucleic acid sequence complementary to a nucleic acid sequence of interest sought to be identified, quantified or sequenced.
32. The non-porous solid support of claims 1, 2, 3, 4 or 5, wherein said non-porous solid support comprises glass or plastic.
33. The non-porous solid support of claims 1, 2, 3, 4 or 5, wherein said non-porous solid support comprises a plate or plates, a well or wells, a microtiter well or microtiter wells, a depression or depressions, a tube or tubes, or a cuvette or cuvettes.
34. The non-porous solid support of claims 1, 2, 3, 4 or 5, wherein said non-porous solid support has been treated with a surface treatment agent, a blocking agent, or both.
35. The non-porous solid support of claim 34, wherein said surface treatment agent comprises an amine providing compound, an epoxy glue or solution, an acid solution, or ammonium acetate.
36. The non-porous solid support of claim 34, wherein said blocking agent comprises Denhardt's solution.
37. The non-porous solid support of claim 35, wherein said acid compound comprises nitric acid.
38. The non-porous solid support of claims 1, 2, 3, 4 or 5, wherein said fixation or immobilization to said non-porous solid support is covalent.
39. The non-porous solid support of claims 1, 2, 3, 4 or 5, wherein said non-porous solid support is transparent or translucent.
40. The non-porous solid support of claims 1, 2, 3, 4 or 5, wherein said non-porous solid support comprises a plate or plates.
41. The non-porous solid support of claims 1, 2, 3, 4 or 5, wherein said non-porous solid support comprises a well or wells, a microtiter well or microtiter wells, or a depression or depressions.
42. The non-porous solid support of claim 35, wherein said amine providing compound comprises dodecadiamine (DDA), polylysine (PPL) or 6-aminohexane.
43. The non-porous solid support of claims 2, 3 or 5, wherein one strand of said at least one double-stranded nucleic acid is fixed or immobilized to said non-porous solid support and the other strand of said at least one double-stranded nucleic acid is hybridized to said one strand.
44. The non-porous solid support of claims 2, 3 or 5, wherein said nucleic acid is DNA.
45. The non-porous solid support of claims 2, 3 or 5, wherein said non-radioactive signaling moiety comprises a chromagen or a chromagenic compound.
46. The non-porous solid support of claims 2, 3 or 5, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by photometric techniques.
47. The non-porous solid support of claims 2, 3 or 5, comprising more than one double-stranded nucleic acid.
48. The non-porous solid support of claims 2, 3 or 5, wherein said nucleic acid is RNA.
49. The non-porous solid support of claims 2, 3 or 5, wherein said nucleic acid comprises both DNA and RNA.
50. The non-porous solid support of claims 2, 3 or 5, wherein said non-radioactive signaling moiety is a colored dye compound.
51. The non-porous solid support of claims 2, 3 or 5, wherein said non-radioactive signaling moiety is a fluorogen or a fluorescent compound.
52. The non-porous solid support of claims 2, 3 or 5, wherein said non-radioactive signaling moiety is a chemiluminescent compound.
53. The non-porous solid support of claims 2, 3 or 5, wherein said non-radioactive signaling moiety comprises a chelating compound.
54. The non-porous solid support of claims 2, 3 or 5, wherein said non-radioactive signaling moiety comprises an enzyme or an enzymatic compound.
55. The non-porous solid support of claims 2, 3 or 5, wherein said non-radioactive signaling moiety comprises a coenzyme.
56. The non-porous solid support of claims 2, 3 or 5, wherein said non-radioactive signaling moiety comprises a biotin.
57. The non-porous solid support of claims 2, 3 or 5, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by spectrophotometric techniques.
58. The non-porous solid support of claims 2, 3 or 5, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by colorimetric techniques.
59. The non-porous solid support of claims 2, 3 or 5, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by fluorometric techniques.
60. The non-porous solid support of claims 2, 3 or 5, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by chemiluminescent techniques.
61. The non-porous solid support of claims 1 or 4, wherein said nucleic acid is DNA.
62. The non-porous solid support of claims 1 or 4, wherein said single-stranded nucleic acid is unlabeled.
63. The non-porous solid support of claims 1 or 4, comprising more than one single-stranded nucleic acid.
64. The non-porous solid support of claims 1 or 4, wherein said nucleic acid is RNA.
65. The non-porous solid support of claims 2 or 3, wherein one strand of said at least one double-stranded nucleic acid comprises a nucleic acid sequence of interest sought to be identified, quantified or sequenced.
66. The non-porous solid support of claims 2 or 3, wherein said non-radioactive signaling moiety is quantifiable in or from a fluid or solution, said quantity being proportional to the amount or quantity of said non-radioactive signaling moiety.
67. The non-porous solid support of claims 2 or 3, wherein said non-porous solid support is transparent or translucent, and said non-radioactive signaling moiety is quantifiable in or from a fluid or solution or from said non-porous solid support, said quantity being proportional to the amount or quantity of said non-radioactive signaling moiety.
68. The system of claim 6, wherein said nucleic acid comprises a nucleic acid sequence complementary to a nucleic acid sequence of interest sought to be identified, quantified or sequenced.
69. The system of claim 6, wherein said single-stranded nucleic acid is unlabeled.
70. The system of claim 6, comprising more than one single-stranded nucleic acid.
71. The system of claim 7, wherein said bridging moiety comprises biotin-avidin, biotin-streptavidin or sugar-lectin.
72. The system of claims 6, 7, 8, 9, 10 or 11, wherein said non-porous solid support comprises glass or plastic.
73. The system of claims 6, 7, 8, 9, 10, or 11, wherein said non-porous solid support comprises a plate or plates, a well or wells, a microtiter well or microtiter wells, a depression or depressions, a tube or tubes, or a cuvette or cuvettes.
74. The system of claims 6, 7, 8, 9, 10 or 11, wherein said non-porous solid support has been treated with a surface treatment agent, a blocking agent, or both.
75. The system of claim 74, wherein said surface treatment agent comprises an amine providing compound, an epoxy glue or solution, an acid solution or ammonium acetate.
76. The system of claim 75, wherein said acid compound comprises nitric acid.
77. The system of claim 74, wherein said blocking agent comprises Denhardt's solution.
78. The system of claims 6, 7, 8, 8, 10 or 11, wherein said fixation or immobilization to said non-porous solid support is covalent.
79. The system of claims 6, 7, 8, 9, 10 or 11, wherein said fixation or immobilization to said non-porous solid support is non-covalent.
80. The system of claims 6, 7, 8, 9, 10 or 11 wherein said non-porous solid support is transparent or translucent.
81. The system of claims 7, 10 or 11, wherein one strand of said double-stranded nucleic acid is fixed or immobilized to said non-porous solid support and the other nucleic acid strand of said double-stranded nucleic acid is hybridized to said one strand.
82. The system of claims 7, 10 or 11, wherein said nucleic acid is DNA.
83. The system of claims 7, 10 or 11, wherein said non-radioactive signaling moiety comprises a chromagen or a chromagenic compound.
84. The system of claims 7, 10 or 11, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by photometric techniques.
85. The system of claims 7, 10 or 11, comprising more than one double-stranded nucleic acid.
86. The system of claims 7, 10 or 11, wherein one strand of said double-stranded nucleic acid is fixed or immobilized to said non-porous solid support and the other strand of said double-stranded nucleic acid is hybridized to said one strand.
87. The system of claims 7, 10 or 11, wherein said nucleic acid comprises RNA.
88. The system of claims 7, 10 or 11, wherein said nucleic acid comprises both DNA and RNA.
89. The system of claims 7, 10 or 11, wherein said non-radioactive signaling moiety comprises a colored dye compound.
90. The system of claims 7, 10 or 11, wherein said non-radioactive signaling moiety comprises a fluorogen or a fluorescent compound.
91. The system of claims 7, 10 or 11, wherein said non-radioactive signaling moiety comprises a chemiluminescent compound.
92. The system of claims 7, 10 or 11, wherein said non-radioactive signaling moiety comprises a chelating compound.
93. The system of claims 7, 10 or 11, wherein said non-radioactive signaling moiety comprises an enzyme or an enzymatic compound.
94. The system of claims 7, 10 or 11, wherein said non-radioactive signaling moiety comprises a coenzyme.
95. The system of claims 7, 10 or 11, wherein said non-radioactive signaling moiety comprises a biotin.
96. The system of claims 7, 10 or 11, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by spectrophotometric techniques.
97. The system of claims 7, 10 or 11, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by colorimetric techniques.
98. The system of claims 7, 10 or 11, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by fluorometric techniques.
99. The system of claims 7, 10 or 11, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by chemiluminescent techniques.
100. The system of claims 6 or 9, wherein said nucleic acid is DNA.
101. The system of claims 6 or 9, wherein said nucleic acid is RNA.
102. The system of claims 7 or 16, wherein one strand of said at least one double-stranded nucleic acid comprises a nucleic acid sequence of interest sought to be identified, quantified or sequenced.
103. The system of claims 7 or 16, wherein said non-radioactive signaling moiety is quantifiable in or from a fluid or solution, said quantity being proportional to the amount or quantity of said non-radioactive signaling moiety.
104. The system of claims 7 or 16, wherein said non-porous solid support is transparent or translucent, and said non-radioactive signaling moiety is quantifiable in or from a fluid or solution or from said non-porous solid support, said quantity being proportional to the amount or quantity of said non-radioactive signaling moiety.
105. The array of claims 17, 18, 19, 20, 21 or 22, wherein said non-porous solid support comprises glass or plastic.
106. The array of claims 17, 18, 19, 20, 21 or 22, wherein said non-porous solid support comprises a plate or plates, a well or wells, a microtiter well or microtiter wells, a depression or depressions, a tube or tubes, or a cuvette or cuvettes.
107. The array of claims 17, 18, 19, 20, 21 or 22, comprising one or more amines.
108. The array of claims 17, 18, 19, 20, 21 or 22, wherein said non-porous solid support has been treated with a surface treatment agent, a blocking agent, or both.
109. The array of claim 108, wherein said surface treatment agent comprises an amine providing compound, an epoxy glue or solution, an acid solution or ammonium acetate.
110. The array of claim 109, wherein said amine providing compound comprises dodecadiamine (DDA), polylysine (PPL) or 6-aminohexane.
111. The array of claim 109, wherein said acid compound comprises nitric acid.
112. The array of claim 108, wherein said blocking agent comprises Denhardt's solution.
113. The array of claims 17, 18, 19, 20, 21 or 22, wherein said fixation or immobilization to said non-porous solid support is covalent.
114. The array of claims 17, 18, 19, 20, 21 or 22, wherein said fixation or immobilization to said non-porous solid support is non-covalent.
115. The array of claims 17, 18, 19, 20, 21 or 22, wherein said non-porous solid support is transparent or translucent.
116. The array of claims 17, 18, 19, 20, 21 or 22, wherein said fixation or immobilization is not to a cell fixed in situ to said non-porous solid support.
117. The array of claims 17, 18, 19, 20, 21 or 22, wherein said non-porous solid support comprises an arrangement of wells, tubes or cuvettes.
118. The array of claims 17, 18, 19, 20, 21 or 22, wherein said non-porous solid support comprises a plate or plates.
119. The array of claims 17, 18, 19, 20, 21 or 22, wherein said non-porous solid support comprises a well or wells, a microtiter well or microtiter wells, or a depression or depressions.
120. The array of claim 17, 18, 19, 20, 21 or 22, wherein said non-porous solid support comprises one or more hydroxyls.
121. The array of claim 17, 18, 19, 20, 21 or 22, wherein said non-porous solid support comprises one or more epoxides.
122. The array of claims 18 or 20, wherein the first strands of said double-stranded nucleic acids are fixed or immobilized to said non-porous solid support and the other nucleic acid strands of said double-stranded nucleic acids are hybridized to said first strands.
123. The array of claims 18 or 20, wherein said nucleic acids is DNA.
124. The array of claims 18 or 20, wherein the first strands of said double-stranded nucleic acids are fixed or immobilized to said non-porous solid support and the other nucleic acid strands of said double-stranded nucleic acids are hybridized to said first strands.
125. The array of claims 18 or 20, wherein one strand of said at least one double-stranded nucleic acid is fixed or immobilized to said non-porous solid support by sandwich hybridization.
126. The array of claims 18 or 20, wherein said nucleic acids is RNA.
127. The array of claims 18 or 02, wherein said nucleic acids comprises both DNA and RNA.
128. The array of claims 17 or 19, wherein said nucleic acids is DNA.
129. The array of claims 17 or 19, wherein said single-stranded nucleic acids are unlabeled.
130. The array of claims 17 or 19, wherein said nucleic acids is RNA.
131. The array of claims 17 or 23, wherein said nucleic acids comprise nucleic acid sequences complementary to nucleic acid sequences of interest sought to be identified, quantified or sequenced.
132. The array of claims 18 or 24, wherein one strand of said double-stranded nucleic acids comprises a nucleic acid sequence of interest sought to be identified, quantified or sequenced.
133. The array of claims 18 or 24, wherein said non-radioactive signaling moiety is quantifiable in or from a fluid or solution, said quantity being proportional to the amount or quantity of said label or labels.
134. The array of claims 18 or 42, wherein said non-porous solid support is transparent or translucent, and said non-radioactive signaling moiety is quantifiable in or from a fluid or solution or from said non-porous solid support, said quantity being proportional to the amount or quantity of said non-radioactive signaling moiety.
135. The array of claims 18, 20, 21 or 22, wherein said non-radioactive signaling moiety comprises a chromagen or a chromagenic compound.
136. The array of claims 18, 20, 21 or 22, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by photometric techniques.
137. The array of claims 18, 20, 21 or 22, wherein said non-radioactive signaling moiety is attached to said at least one nucleic acid strand through a bridging moiety.
138. The array of claim 137, wherein said bridging moiety comprises biotin-avidin, biotin-streptavidin or sugar-lectin.
139. The array of claims 18, 20, 21 or 22, wherein said non-radioactive signaling moiety is a colored dye compound.
140. The array of claims 18, 20, 21 or 22, wherein said non-radioactive signaling moiety is a fluorogen or a fluorescent compound.
141. The array of claims 18, 20, 21 or 22, wherein said non-radioactive signaling moiety is a chemiluminescent compound.
142. The array of claims 18, 20, 21 or 22, wherein said non-radioactive signaling moiety is a chelating compound.
143. The array of claims 18, 20, 21 or 22, wherein said non-radioactive signaling moiety is an enzyme or an enzymatic compound.
144. The array of claims 18, 20, 21 or 22, wherein said non-radioactive signaling moiety is a coenzyme.
145. The array of claims 18, 20, 21 or 22, wherein said non-radioactive signaling moiety is biotin.
146. The array of claims 18, 20, 21 or 22, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by spectrophotometric techniques.
147. The array of claims 18, 20, 21 or 22, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by colorimetric techniques.
148. The array of claims 18, 20, 21 or 22, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by fluorometric techniques.
149. The array of claims 18, 20, 21 or 22, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by chemiluminescent techniques.
150. The array of claim 25, wherein said nucleic acids are DNA.
151. The array of claim 25, wherein said nucleic acids comprise a gene sequence or pathogen sequence.
152. The array of claim 25, wherein said single-stranded nucleic acids are unlabeled.
153. The array of claims 25 or 26, wherein said non-porous solid support is transparent or translucent.
154. The array of claim 25, wherein said nucleic acids are RNA.
155. The array of claim 26, wherein the first strands of said double-stranded nucleic acids are fixed or immobilized to said non-porous solid support and the other nucleic acid strands of said double-stranded nucleic acids are hybridized to said first strands.
156. The array of claim 26, wherein said nucleic acids are DNA.
157. The array of claim 26, wherein one strand of said double-stranded nucleic acids comprises a gene sequence or pathogen sequence.
158. The array of claim 26, wherein said non-radioactive signaling moiety is quantifiable in or from a fluid or solution, said quantity being proportional to the amount or quantity of said non-radioactive signaling moiety.
159. The array of claim 26, wherein said non-porous solid support is transparent or translucent, and said non-radioactive signaling moiety is quantifiable in or from a fluid or solution or from said non-porous solid support, said quantity being proportional to the amount or quantity of said non-radioactive signaling moiety.
160. The array of claim 26, wherein said non-radioactive signaling moiety comprises a chromagen or a chromagenic compound.
161. The array of claim 26, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by photometric techniques.
162. The array of claim 26, wherein said at least one non-radioactive signaling moiety is attached to said at least one nucleic acid strand through a bridging moiety.
163. The array of claim 162, wherein said bridging moiety comprises biotin-avidin, biotin-streptavidin or sugar-lectin.
164. The array of claim 26, wherein one strand of various double-stranded nucleic acids is fixed or immobilized to said non-porous solid support by sandwich hybridization.
165. The array of claim 26, wherein said nucleic acids are RNA.
166. The array of claim 26, wherein said nucleic acids comprise both DNA and RNA.
167. The array of claim 26, wherein said non-radioactive signaling moiety comprises a colored dye compound.
168. The array of claim 26, wherein said non-radioactive signaling moiety comprises a fluorescent compound.
169. The array of claim 26, wherein said non-radioactive signaling moiety comprises a chemiluminescent compound.
170. The array of claim 26, wherein said non-radioactive signaling moiety comprises a chelating compound.
171. The array of claim 26, wherein said non-radioactive signaling moiety comprises an enzyme or an enzymatic compound.
172. The array of claim 26, wherein said non-radioactive signaling moiety comprises a coenzyme.
173. The array of claim 26, wherein said non-radioactive signaling moiety comprises a biotin.
174. The array of claim 26, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by spectrophotometric techniques.
175. The array of claim 26, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by colorimetric techniques.
176. The array of claim 26, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by fluorometric techniques.
177. The array of claim 26, wherein a non-radioactive signal from said non-radioactive signaling moiety is quantifiable or detectable by chemiluminescent techniques.
178. The array of claims 25 or 26, wherein said non-porous solid support comprises glass or plastic.
179. The array of claims 25 or 26, wherein said non-porous solid support comprises one or more amines.
180. The array of claims 25 or 26, wherein said non-porous solid support has been treated with a surface treatment agent, a blocking agent, or both.
181. The array of claim 180, wherein said surface treatment agent comprises an amine providing compound, an epoxy glue or solution, an acid solution or ammonium acetate.
182. The array of claim 181, wherein said amine providing compound comprises dodecadiamine (DDA), polylysine (PPL) or 6-aminohexane.
183. The array of claim 181, wherein said acid compound comprises nitric acid.
184. The array of claim 180, wherein said blocking agent comprises Denhardt's solution.
185. The array of claims 25 or 26, wherein said fixation or immobilization to said non-porous solid support is covalent.
186. The array of claims 25 or 26, wherein said fixation or immobilization to said non-porous solid support is non-covalent.
187. The array of claims 25 or 26, wherein said fixation or immobilization is not to a cell fixed in situ to said non-porous solid support.
188. The array of claims 25 or 26, wherein said non-porous solid support comprises an arrangement of said wells.
189. The array of claim 25 or 26, wherein said non-porous solid support comprises one or more hydroxyls.
190. The array of claim 25 or 26, wherein said non-porous solid support comprises one or more epoxides.
191. The non-porous glass or non-porous plastic solid support of claim 27, wherein said nucleic acid is DNA.
192. The non-porous glass or non-porous plastic solid support of claim 27, wherein said nucleic acid comprises a nucleic acid sequence complementary to a nucleic acid sequence of interest sought to be identified, quantified or sequenced.
193. The non-porous glass or non-porous plastic solid support of claim 27, wherein said single-stranded nucleic acid is unlabeled.
194. The non-porous glass or non-porous plastic solid support of claim 27, comprising more than one single-stranded nucleic acid fixed or immobilized in hybridizable form to said non-porous glass or non-porous plastic solid support.
195. The non-porous glass or non-porous plastic solid support of claim 27, wherein said nucleic acid is RNA.
196. The non-porous glass or non-porous plastic solid support of claim 28, wherein said nucleic acid is DNA.
197. The non-porous glass or non-porous plastic solid support of claim 28, wherein one strand of said at least one double-stranded nucleic acid comprises a nucleic acid sequence of interest sought to be identified, quantified or sequenced.
198. The non-porous glass or non-porous plastic solid support of claim 28, wherein said non-radioactive signaling moiety is quantifiable in or from a fluid or solution, said quantity being proportional to the amount or quantity of said label or labels.
199. The non-porous glass or non-porous plastic solid support of claim 28, comprising more than one double-stranded nucleic acid fixed or immobilized in hybridizable form to said non-porous glass or non-porous plastic solid support.
200. The non-porous glass or non-porous plastic solid support of claim 28, wherein said bridging moiety comprises biotin-avidin, biotin-streptavidin or sugar-lectin.
201. The non-porous glass or non-porous plastic solid support of claim 28, wherein said non-radioactive signaling moiety comprises a chromagen or a chromagenic compound.
202. The non-porous glass or non-porous plastic solid support of claim 28, wherein one strand of said at least one double-stranded nucleic acid is fixed or immobilized to said non-porous solid support by sandwich hybridization.
203. The non-porous glass or non-porous plastic solid support of claim 28, wherein said nucleic acid is RNA.
204. The non-porous glass or non-porous plastic solid support of claim 28, wherein said nucleic acid comprises both DNA and RNA.
205. The non-porous glass or non-porous plastic solid support of claim 28, wherein said non-radioactive signaling moiety comprises a colored dye compound.
206. The non-porous glass or non-porous plastic solid support of claim 28, wherein said non-radioactive signaling moiety comprises a fluorescent compound.
207. The non-porous glass or non-porous plastic solid support of claim 28, wherein said non-radioactive signaling moiety comprises a chemiluminescent compound.
208. The non-porous glass or non-porous plastic solid support of claim 28, wherein said non-radioactive signaling moiety comprises a chelating compound.
209. The non-porous glass or non-porous plastic solid support of claim 28, wherein said non-radioactive signaling moiety comprises an enzyme or an enzymatic compound.
210. The non-porous glass or non-porous plastic solid support of claim 28, wherein said non-radioactive signaling moiety comprises a coenzyme.
211. The non-porous glass or non-porous plastic solid support of claim 28, wherein said non-radioactive signaling moiety comprises a biotin.
212. The non-porous glass or non-porous plastic solid support of claims 27 or 28, wherein said non-porous glass or non-porous plastic solid support comprises a plate or plates, a well or wells, a microtiter well or microtiter wells, a depression or depressions, a tube or tubes, or a cuvette or cuvettes.
213. The non-porous glass or non-porous plastic solid support of claims 27 or 28, wherein said non-porous glass or non-porous plastic solid support has been treated with a surface treatment agent, a blocking agent, or both.
214. The non-porous glass or non-porous plastic solid support of claim 213, wherein said surface treatment agent comprises an amine providing compound, an epoxy glue or solution, an acid solution or ammonium acetate.
215. The non-porous glass or non-porous plastic solid support of claim 214, wherein said amine providing compound comprises dodecadiamine (DDA), polylysine (PPL) or 6-aminohexane.
216. The non-porous glass or non-porous plastic solid support of claim 214, wherein said acid compound comprises nitric acid.
217. The non-porous glass or non-porous plastic solid support of claim 213, wherein said blocking agent comprises Denhardt's solution.
218. The non-porous glass or non-porous plastic solid support of claims 27 or 28, wherein said fixation or immobilization to said non-porous glass or non-porous plastic solid support is covalent.
219. The non-porous glass or non-porous plastic solid support of claims 27 or 28, wherein said fixation or immobilization to said non-porous glass or non-porous plastic solid support is non-covalent.
220. The non-porous glass or non-porous plastic solid support of claim 28, wherein one strand of said double-stranded nucleic acid is fixed or immobilized to said non-porous glass or non-porous plastic solid support by sandwich hybridization or by hybridization to a complementary nucleic acid strand or sequence.
221. The non-porous glass or non-porous plastic solid support of claims 27 or 28, wherein said non-porous glass or non-porous plastic solid support is transparent or translucent.
222. The non-porous glass or non-porous plastic solid support of claims 27 or 28, wherein said fixation or immobilization is not to a cell fixed in situ to said non-porous solid support.
223. The non-porous glass or non-porous plastic solid support of claims 27 or 28, wherein said non-porous solid support comprises an arrangement of wells, tubes or cuvettes.
224. The non-porous glass or non-porous plastic solid support of claims 27 or 28, wherein said non-porous glass or non-porous plastic solid support comprises a plate or plates.
225. The non-porous glass or non-porous plastic solid support of claims 27 or 28, wherein said non-porous glass or non-porous plastic solid support comprises a well or wells, a microtiter well or microtiter wells, or a depression or depressions.
226. The non-porous solid support of claims 12, 13, 14, 15, 29 or 30, wherein said non-porous solid support comprises glass or plastic.
227. The system of claims 8, 9, 10 or 11, wherein said non-porous solid support comprises glass or plastic.
228. The non-porous solid support of claims 2, 29, 30, 3 or 5, wherein said bridging moiety comprises biotin-avidin, biotin-streptavidin or sugar-lectin.
229. The non-porous solid support of claims 2, 29, 30, 3 or 5, wherein one strand of said at least one double-stranded nucleic acid is fixed or immobilized to said non-porous solid support by sandwich hybridization.
230. The system of claims 6, 7, 8 or 9, wherein said fixation or immobilization is not to a cell fixed in situ to said non-porous solid support.
231. The system of claims 6, 7, 8, 9, 10 or 11, wherein said non-porous solid support comprises an arrangement of wells, tubes or cuvettes.
232. The system of claims 6, 7, 8, 9, 10 or 11, wherein said non-porous solid support comprises a plate or plates.
233. The system of claims 6, 7, 8, 9, 10 or 11, wherein said non-porous solid support comprises a well or wells, a microtiter well or microtiter wells, or a depression or depressions.
234. The non-porous solid support of claim 22 or 5, wherein said non-porous solid support comprises one or more hydroxyls.
235. The non-porous solid support of claim 3 or 5, wherein said non-porous solid support comprises one or more epoxides.
236. The non-porous solid support of claims 1, 2, 3, 4 or 5, wherein said fixation or immobilization to said non-porous solid support is non-covalent.
237. The non-porous glass or non-porous plastic solid support of claim 28, wherein said non-porous glass or non-porous plastic solid support is transparent or translucent, and non-radioactive signaling moiety is quantifiable in or from a fluid or solution or from said non-porous glass or non-porous plastic solid support, said quantity being proportional to the amount or quantity of said non-radioactive signaling moiety.
238. The system of claim 75, wherein said amine providing compound comprises dodecadiamine (DDA), polylysine (PPL) or 6-aminohexane.
US08486070 1983-01-27 1995-06-07 System, array and non-porous solid support comprising fixed or immobilized nucleic acids Active US7064197B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US46146983 true 1983-01-27 1983-01-27
US73237485 true 1985-05-09 1985-05-09
US07385986 US4994373A (en) 1983-01-27 1989-07-20 Method and structures employing chemically-labelled polynucleotide probes
US60734790 true 1990-10-30 1990-10-30
US96764692 true 1992-10-28 1992-10-28
US08486070 US7064197B1 (en) 1983-01-27 1995-06-07 System, array and non-porous solid support comprising fixed or immobilized nucleic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08486070 US7064197B1 (en) 1983-01-27 1995-06-07 System, array and non-porous solid support comprising fixed or immobilized nucleic acids

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US96764692 Continuation 1992-10-28 1992-10-28

Publications (1)

Publication Number Publication Date
US7064197B1 true US7064197B1 (en) 2006-06-20

Family

ID=27409742

Family Applications (2)

Application Number Title Priority Date Filing Date
US07385986 Expired - Lifetime US4994373A (en) 1983-01-27 1989-07-20 Method and structures employing chemically-labelled polynucleotide probes
US08486070 Active US7064197B1 (en) 1983-01-27 1995-06-07 System, array and non-porous solid support comprising fixed or immobilized nucleic acids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US07385986 Expired - Lifetime US4994373A (en) 1983-01-27 1989-07-20 Method and structures employing chemically-labelled polynucleotide probes

Country Status (1)

Country Link
US (2) US4994373A (en)

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040106110A1 (en) * 1998-07-30 2004-06-03 Solexa, Ltd. Preparation of polynucleotide arrays
US20050009077A1 (en) * 2001-06-30 2005-01-13 Enzo Life Sciences Inc., Composition of matter comprising library of first nucleic acid analyte copies
US20070037152A1 (en) * 2003-02-26 2007-02-15 Drmanac Radoje T Random array dna analysis by hybridization
US20070036511A1 (en) * 2005-08-11 2007-02-15 Pacific Biosciences Of California, Inc. Methods and systems for monitoring multiple optical signals from a single source
US20070072196A1 (en) * 2005-09-29 2007-03-29 Pacific Biosciences Of California, Inc. Fluorescent nucleotide analogs and uses therefor
US20070099208A1 (en) * 2005-06-15 2007-05-03 Radoje Drmanac Single molecule arrays for genetic and chemical analysis
US20070128133A1 (en) * 2005-12-02 2007-06-07 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US20070168197A1 (en) * 2006-01-18 2007-07-19 Nokia Corporation Audio coding
US20070188750A1 (en) * 2006-02-13 2007-08-16 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US20070206187A1 (en) * 2006-02-13 2007-09-06 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US20070281863A1 (en) * 2001-06-30 2007-12-06 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20080030628A1 (en) * 2006-02-13 2008-02-07 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US20080032301A1 (en) * 2006-03-30 2008-02-07 Pacific Biosciences Of California, Inc. Articles having localized molecules disposed thereon and methods of producing same
US20080038725A1 (en) * 2005-06-20 2008-02-14 Yuling Luo Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
US20080039339A1 (en) * 2006-06-05 2008-02-14 Arjang Hassibi Real Time Microarrays
US20080050747A1 (en) * 2006-03-30 2008-02-28 Pacific Biosciences Of California, Inc. Articles having localized molecules disposed thereon and methods of producing and using same
US20080080059A1 (en) * 2006-09-28 2008-04-03 Pacific Biosciences Of California, Inc. Modular optical components and systems incorporating same
US20080128627A1 (en) * 2006-09-01 2008-06-05 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US20080171331A1 (en) * 2006-11-09 2008-07-17 Complete Genomics, Inc. Methods and Compositions for Large-Scale Analysis of Nucleic Acids Using DNA Deletions
US20080176757A1 (en) * 2006-07-28 2008-07-24 Arjang Hassibi Multiplex Q-PCR Arrays
US20080221832A1 (en) * 2006-11-09 2008-09-11 Complete Genomics, Inc. Methods for computing positional base probabilities using experminentals base value distributions
US20080237021A1 (en) * 2007-03-30 2008-10-02 Intermec Technologies Corporation Keypad overlay membrane
US20080277595A1 (en) * 2007-05-10 2008-11-13 Pacific Biosciences Of California, Inc. Highly multiplexed confocal detection systems and methods of using same
US20080318796A1 (en) * 2006-10-27 2008-12-25 Complete Genomics,Inc. Efficient arrays of amplified polynucleotides
US20090005252A1 (en) * 2006-02-24 2009-01-01 Complete Genomics, Inc. High throughput genome sequencing on DNA arrays
US20090011943A1 (en) * 2005-06-15 2009-01-08 Complete Genomics, Inc. High throughput genome sequencing on DNA arrays
US20090061430A1 (en) * 2005-09-30 2009-03-05 Pacific Biosciences Of California, Inc. Reactive surfaces, substrates and methods of producing and using same
US20090081688A1 (en) * 2005-06-20 2009-03-26 Advanced Cell Diagnostics Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
US20090111115A1 (en) * 2007-10-15 2009-04-30 Complete Genomics, Inc. Sequence analysis using decorated nucleic acids
US20090176652A1 (en) * 2007-11-06 2009-07-09 Complete Genomics, Inc. Methods and Oligonucleotide Designs for Insertion of Multiple Adaptors into Library Constructs
US20090176234A1 (en) * 2007-11-05 2009-07-09 Complete Genomics, Inc. Efficient base determination in sequencing reactions
US7563574B2 (en) 2006-03-31 2009-07-21 Pacific Biosciences Of California, Inc. Methods, systems and compositions for monitoring enzyme activity and applications thereof
US20090203551A1 (en) * 2007-11-05 2009-08-13 Complete Genomics, Inc. Methods and Oligonucleotide Designs for Insertion of Multiple Adaptors Employing Selective Methylation
US20090263802A1 (en) * 2008-01-28 2009-10-22 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US20090270273A1 (en) * 2008-04-21 2009-10-29 Complete Genomics, Inc. Array structures for nucleic acid detection
US20090318304A1 (en) * 2007-11-29 2009-12-24 Complete Genomics, Inc. Efficient Shotgun Sequencing Methods
US20100065726A1 (en) * 2006-09-01 2010-03-18 Pacific Biosciences Of California, Inc. Substrates and optical systems and methods of use thereof
US20100081128A1 (en) * 2005-10-07 2010-04-01 Radoje Drmanac Self-assembled single molecule arrays and uses thereof
US20100105052A1 (en) * 2007-10-29 2010-04-29 Complete Genomics, Inc. Nucleic acid sequencing and process
US20100130368A1 (en) * 1998-07-30 2010-05-27 Shankar Balasubramanian Method and system for sequencing polynucleotides
US20100167413A1 (en) * 2007-05-10 2010-07-01 Paul Lundquist Methods and systems for analyzing fluorescent materials with reduced autofluorescence
WO2012027195A1 (en) 2010-08-24 2012-03-01 Enzo Biochem, Inc. Assays for detecting modified compounds
US8207509B2 (en) 2006-09-01 2012-06-26 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US8501406B1 (en) 2009-07-14 2013-08-06 Pacific Biosciences Of California, Inc. Selectively functionalized arrays
US8592150B2 (en) 2007-12-05 2013-11-26 Complete Genomics, Inc. Methods and compositions for long fragment read sequencing
US8658361B2 (en) 2010-10-21 2014-02-25 Advanced Cell Diagnostics, Inc. Ultra sensitive method for in situ detection of nucleic acids
US8834847B2 (en) 2010-08-12 2014-09-16 Pacific Biosciences Of California, Inc. Photodamage mitigation compounds and systems
US9068948B2 (en) 2002-03-12 2015-06-30 Enzo Life Sciences, Inc. Processes for detection of nucleic acids
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
US9524369B2 (en) 2009-06-15 2016-12-20 Complete Genomics, Inc. Processing and analysis of complex nucleic acid sequence data
US9739773B1 (en) 2010-08-13 2017-08-22 David Gordon Bermudes Compositions and methods for determining successful immunization by one or more vaccines
US9833761B2 (en) 2013-08-05 2017-12-05 Twist Bioscience Corporation De novo synthesized gene libraries
US9890411B2 (en) 2011-02-16 2018-02-13 Waters Technologies Corporation Immobilized enzymatic reactor
US9895673B2 (en) 2015-12-01 2018-02-20 Twist Bioscience Corporation Functionalized surfaces and preparation thereof

Families Citing this family (223)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994373A (en) * 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
US5849478A (en) * 1986-08-14 1998-12-15 Cashman; Daniel P. Blocked-polymerase polynucleotide immunoassay method and kit
US5714380A (en) 1986-10-23 1998-02-03 Amoco Corporation Closed vessel for isolating target molecules and for performing amplification
US20050019760A1 (en) * 1988-03-05 2005-01-27 Oxford Gene Technology Limited Analysing polynucleotide sequences
GB8810400D0 (en) * 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US7811751B2 (en) * 1988-05-03 2010-10-12 Oxford Gene Technology Limited Analysing polynucleotide sequences
US6054270A (en) * 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
JP4511636B2 (en) * 1995-04-03 2010-07-28 ウィスコンシン アルムニ リサーチ ファウンデーション How to measure the physical properties of the nucleic acid by microscopic imaging
US6955915B2 (en) * 1989-06-07 2005-10-18 Affymetrix, Inc. Apparatus comprising polymers
US6468740B1 (en) 1992-11-05 2002-10-22 Affymetrix, Inc. Cyclic and substituted immobilized molecular synthesis
US6406844B1 (en) 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US6506558B1 (en) 1990-03-07 2003-01-14 Affymetrix Inc. Very large scale immobilized polymer synthesis
US6919211B1 (en) * 1989-06-07 2005-07-19 Affymetrix, Inc. Polypeptide arrays
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5547839A (en) * 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US5925525A (en) * 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
US6551784B2 (en) 1989-06-07 2003-04-22 Affymetrix Inc Method of comparing nucleic acid sequences
US6309822B1 (en) 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6416952B1 (en) 1989-06-07 2002-07-09 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US20030211555A1 (en) * 1992-07-10 2003-11-13 Jaffe Russell M. Assay for evaluation of cellular response to allergens
US5288644A (en) * 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5695926A (en) * 1990-06-11 1997-12-09 Bio Merieux Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support
US5254475A (en) * 1990-08-13 1993-10-19 City Of Hope Sequential C-terminal degradation of peptides and proteins
DE69132843D1 (en) 1990-12-06 2002-01-10 Affymetrix Inc Identifying nucleic acids in samples
FR2679255B1 (en) * 1991-07-17 1993-10-22 Bio Merieux Method for immobilization of a nucleic fragment by passive fixation on a solid support, the solid support thus obtained and its use.
EP0648281A4 (en) * 1991-09-10 1997-06-04 Jack D Love Dna/rna target and signal amplification.
US5846708A (en) * 1991-11-19 1998-12-08 Massachusetts Institiute Of Technology Optical and electrical methods and apparatus for molecule detection
US6864101B1 (en) 1991-11-22 2005-03-08 Affymetrix, Inc. Combinatorial strategies for polymer synthesis
US6943034B1 (en) * 1991-11-22 2005-09-13 Affymetrix, Inc. Combinatorial strategies for polymer synthesis
DE69233087D1 (en) * 1991-11-22 2003-07-03 Affymetrix Inc N D Ges D Staat A process for the production of polymer arrays
US5380489A (en) * 1992-02-18 1995-01-10 Eastman Kodak Company Element and method for nucleic acid amplification and detection using adhered probes
US5888723A (en) * 1992-02-18 1999-03-30 Johnson & Johnson Clinical Diagnostics, Inc. Method for nucleic acid amplification and detection using adhered probes
WO1993020234A1 (en) * 1992-03-31 1993-10-14 E.I. Du Pont De Nemours And Company A rapid, high capacity nucleic acid based assay
EP0662151A1 (en) * 1992-07-17 1995-07-12 Aprogenex, Inc. Background-reducing compounds for probe-mediated in-situ fluorimetric assays
US20060063193A1 (en) * 1995-04-11 2006-03-23 Dong-Jing Fu Solid phase sequencing of double-stranded nucleic acids
US5795714A (en) * 1992-11-06 1998-08-18 Trustees Of Boston University Method for replicating an array of nucleic acid probes
US6436635B1 (en) * 1992-11-06 2002-08-20 Boston University Solid phase sequencing of double-stranded nucleic acids
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
US6428955B1 (en) 1995-03-17 2002-08-06 Sequenom, Inc. DNA diagnostics based on mass spectrometry
US6194144B1 (en) 1993-01-07 2001-02-27 Sequenom, Inc. DNA sequencing by mass spectrometry
WO1994016104A1 (en) * 1993-01-08 1994-07-21 Ctrc Research Foundation Color imaging system for use in molecular biology
US20030129589A1 (en) 1996-11-06 2003-07-10 Hubert Koster Dna diagnostics based on mass spectrometry
US6140053A (en) * 1996-11-06 2000-10-31 Sequenom, Inc. DNA sequencing by mass spectrometry via exonuclease degradation
US5446137B1 (en) * 1993-12-09 1998-10-06 Behringwerke Ag Oligonucleotides containing 4'-substituted nucleotides
US5824473A (en) 1993-12-10 1998-10-20 California Institute Of Technology Nucleic acid mediated electron transfer
US6071699A (en) 1996-06-07 2000-06-06 California Institute Of Technology Nucleic acid mediated electron transfer
US5591578A (en) * 1993-12-10 1997-01-07 California Institute Of Technology Nucleic acid mediated electron transfer
US5952172A (en) 1993-12-10 1999-09-14 California Institute Of Technology Nucleic acid mediated electron transfer
US5591580A (en) * 1994-03-31 1997-01-07 Johnson & Johnson Clinical Diagnostics, Inc. Method, test element and test kit for semi-quantitative detection of target nucleic acid
DE19518217A1 (en) * 1994-05-11 1995-11-30 Imtec Immundiagnostika Gmbh Determn of DNA after capture by probe immobilised on solid phase
US7323298B1 (en) 1994-06-17 2008-01-29 The Board Of Trustees Of The Leland Stanford Junior University Microarray for determining the relative abundances of polynuceotide sequences
US7378236B1 (en) 1994-06-17 2008-05-27 The Board Of Trustees Of The Leland Stanford Junior University Method for analyzing gene expression patterns
US5622822A (en) 1994-09-13 1997-04-22 Johnson & Johnson Clinical Diagnostics, Inc. Methods for capture and selective release of nucleic acids using polyethyleneimine and an anionic phosphate ester surfactant and amplification of same
US5582988A (en) 1994-09-15 1996-12-10 Johnson & Johnson Clinical Diagnostics, Inc. Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same
US5620850A (en) * 1994-09-26 1997-04-15 President And Fellows Of Harvard College Molecular recognition at surfaces derivatized with self-assembled monolayers
US8236493B2 (en) * 1994-10-21 2012-08-07 Affymetrix, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5922534A (en) * 1995-03-28 1999-07-13 Hewlett-Packard Company Dry biochemical assay plate and method for making the same
US5753787A (en) * 1995-04-10 1998-05-19 Yale University Nucleic acids encoding ancylostoma secreted protein
US7803529B1 (en) * 1995-04-11 2010-09-28 Sequenom, Inc. Solid phase sequencing of biopolymers
US6096508A (en) * 1995-08-16 2000-08-01 Kirkegaard & Perry Laboratoies, Inc. Method of reducing background in biotin-based assays
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
JP3974941B2 (en) 1995-11-21 2007-09-12 イェール ユニバーシティ Unimolecular segment amplification and detection
US5854033A (en) * 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
EP0880598A4 (en) * 1996-01-23 2005-02-23 Affymetrix Inc Nucleic acid analysis techniques
US6387707B1 (en) * 1996-04-25 2002-05-14 Bioarray Solutions Array Cytometry
US7041510B2 (en) 1996-04-25 2006-05-09 Bioarray Solutions Ltd. System and method for programmable illumination pattern generation
US6958245B2 (en) 1996-04-25 2005-10-25 Bioarray Solutions Ltd. Array cytometry
CA2255599C (en) * 1996-04-25 2006-09-05 Bioarray Solutions, Llc Light-controlled electrokinetic assembly of particles near surfaces
US7144119B2 (en) * 1996-04-25 2006-12-05 Bioarray Solutions Ltd. System and method for programmable illumination pattern generation
US20030045005A1 (en) * 2000-10-17 2003-03-06 Michael Seul Light-controlled electrokinetic assembly of particles near surfaces
US6444423B1 (en) 1996-06-07 2002-09-03 Molecular Dynamics, Inc. Nucleosides comprising polydentate ligands
US5902724A (en) * 1996-07-12 1999-05-11 Tm Technologies, Inc. Signal amplification method
US7160678B1 (en) 1996-11-05 2007-01-09 Clinical Micro Sensors, Inc. Compositions for the electronic detection of analytes utilizing monolayers
US7393645B2 (en) * 1996-11-05 2008-07-01 Clinical Micro Sensors, Inc. Compositions for the electronic detection of analytes utilizing monolayers
US7014992B1 (en) * 1996-11-05 2006-03-21 Clinical Micro Sensors, Inc. Conductive oligomers attached to electrodes and nucleoside analogs
US7045285B1 (en) 1996-11-05 2006-05-16 Clinical Micro Sensors, Inc. Electronic transfer moieties attached to peptide nucleic acids
US6096273A (en) 1996-11-05 2000-08-01 Clinical Micro Sensors Electrodes linked via conductive oligomers to nucleic acids
ES2215241T3 (en) 1996-11-06 2004-10-01 Sequenom, Inc. Mass spectrometry procedure.
US6133436A (en) 1996-11-06 2000-10-17 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
US6083763A (en) * 1996-12-31 2000-07-04 Genometrix Inc. Multiplexed molecular analysis apparatus and method
WO1998035012A3 (en) * 1997-02-12 1999-02-11 Eugene Y Chan Methods and products for analyzing polymers
US7381525B1 (en) * 1997-03-07 2008-06-03 Clinical Micro Sensors, Inc. AC/DC voltage apparatus for detection of nucleic acids
US7622294B2 (en) 1997-03-14 2009-11-24 Trustees Of Tufts College Methods for detecting target analytes and enzymatic reactions
EP0878552A1 (en) * 1997-05-13 1998-11-18 Erasmus Universiteit Rotterdam Molecular detection of chromosome aberrations
CA2291853C (en) * 1997-05-23 2013-01-15 Bioarray Solutions Llc Color-encoding and in-situ interrogation of matrix-coupled chemical compounds
US6013459A (en) * 1997-06-12 2000-01-11 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
US6391655B1 (en) * 1997-07-30 2002-05-21 Corning Incorporated Oxidized styrenic polymers for DNA binding
US6221612B1 (en) * 1997-08-01 2001-04-24 Aurora Biosciences Corporation Photon reducing agents for use in fluorescence assays
US6214563B1 (en) 1997-08-01 2001-04-10 Aurora Biosciences Corporation Photon reducing agents for reducing undesired light emission in assays
US6200762B1 (en) 1997-08-01 2001-03-13 Aurora Biosciences Corporation Photon reducing agents and compositions for fluorescence assays
US6762019B2 (en) * 1997-09-30 2004-07-13 Surmodics, Inc. Epoxide polymer surfaces
US6465178B2 (en) * 1997-09-30 2002-10-15 Surmodics, Inc. Target molecule attachment to surfaces
US6124120A (en) 1997-10-08 2000-09-26 Yale University Multiple displacement amplification
US6268131B1 (en) 1997-12-15 2001-07-31 Sequenom, Inc. Mass spectrometric methods for sequencing nucleic acids
US6238869B1 (en) 1997-12-19 2001-05-29 High Throughput Genomics, Inc. High throughput assay system
US20030096232A1 (en) * 1997-12-19 2003-05-22 Kris Richard M. High throughput assay system
US6458533B1 (en) 1997-12-19 2002-10-01 High Throughput Genomics, Inc. High throughput assay system for monitoring ESTs
US20100105572A1 (en) * 1997-12-19 2010-04-29 Kris Richard M High throughput assay system
US20030039967A1 (en) * 1997-12-19 2003-02-27 Kris Richard M. High throughput assay system using mass spectrometry
US6232066B1 (en) 1997-12-19 2001-05-15 Neogen, Inc. High throughput assay system
US6686150B1 (en) 1998-01-27 2004-02-03 Clinical Micro Sensors, Inc. Amplification of nucleic acids with electronic detection
CA2319170A1 (en) 1998-01-27 1999-07-29 Clinical Micro Sensors, Inc. Amplification of nucleic acids with electronic detection
EP1965213A3 (en) 1998-02-04 2009-07-15 Invitrogen Corporation Microarrays and uses therefor
DE69825722T2 (en) * 1998-02-04 2005-08-25 Corning Inc. Substrate for printing a die
US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US6780591B2 (en) * 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
CA2327542C (en) * 1998-05-04 2011-11-22 Dako A/S Method and probes for the detection of chromosome aberrations
US6723564B2 (en) 1998-05-07 2004-04-20 Sequenom, Inc. IR MALDI mass spectrometry of nucleic acids using liquid matrices
US7087148B1 (en) 1998-06-23 2006-08-08 Clinical Micro Sensors, Inc. Binding acceleration techniques for the detection of analytes
US20050244954A1 (en) * 1998-06-23 2005-11-03 Blackburn Gary F Binding acceleration techniques for the detection of analytes
US6761816B1 (en) 1998-06-23 2004-07-13 Clinical Micro Systems, Inc. Printed circuit boards with monolayers and capture ligands
US6290839B1 (en) 1998-06-23 2001-09-18 Clinical Micro Sensors, Inc. Systems for electrophoretic transport and detection of analytes
US20020119579A1 (en) * 1998-07-14 2002-08-29 Peter Wagner Arrays devices and methods of use thereof
US20030138973A1 (en) * 1998-07-14 2003-07-24 Peter Wagner Microdevices for screening biomolecules
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6576478B1 (en) * 1998-07-14 2003-06-10 Zyomyx, Inc. Microdevices for high-throughput screening of biomolecules
US6316229B1 (en) 1998-07-20 2001-11-13 Yale University Single molecule analysis target-mediated ligation of bipartite primers
JP2002525049A (en) 1998-09-15 2002-08-13 イェール ユニバーシティ Molecular cloning using rolling circle amplification
JP2002525078A (en) * 1998-09-15 2002-08-13 イェール ユニバーシティ Artificial long terminal repeat sequence
US6740518B1 (en) * 1998-09-17 2004-05-25 Clinical Micro Sensors, Inc. Signal detection techniques for the detection of analytes
US6541617B1 (en) * 1998-10-27 2003-04-01 Clinical Micro Sensors, Inc. Detection of target analytes using particles and electrodes
US6545264B1 (en) 1998-10-30 2003-04-08 Affymetrix, Inc. Systems and methods for high performance scanning
EP1127167A4 (en) * 1998-11-03 2004-07-14 Saigene Corp Methods for preventing cross-contamination in solid support-based assays
US6833267B1 (en) * 1998-12-30 2004-12-21 Clinical Micro Sensors, Inc. Tissue collection devices containing biosensors
CA2364305A1 (en) 1999-03-31 2000-10-05 The University Of North Carolina At Chapel Hill Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same
US6942771B1 (en) 1999-04-21 2005-09-13 Clinical Micro Sensors, Inc. Microfluidic systems in the electrochemical detection of target analytes
US7262006B1 (en) 2000-05-01 2007-08-28 Ortho-Clinical Diagnostics, Inc. Rapid and efficient capture of DNA from sample without using cell lysing reagent
CA2370122C (en) * 1999-05-04 2011-04-26 Ortho-Clinical Diagnostics, Inc. Rapid and efficient capture of dna from sample without using cell lysing reagent
US7056661B2 (en) 1999-05-19 2006-06-06 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
US7501245B2 (en) * 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
US6818395B1 (en) * 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US6753143B2 (en) 2000-05-01 2004-06-22 Clinical Micro Sensors, Inc. Target analyte detection using asymmetrical self-assembled monolayers
CA2380258C (en) 1999-07-26 2008-07-15 Clinical Micro Sensors, Inc. Sequence determination of nucleic acids using electronic detection
US20020177135A1 (en) * 1999-07-27 2002-11-28 Doung Hau H. Devices and methods for biochip multiplexing
US7057704B2 (en) * 2000-09-17 2006-06-06 Bioarray Solutions Ltd. System and method for programmable illumination pattern generation
US6797521B2 (en) 1999-10-26 2004-09-28 University Of Utah Research Foundation Fluorescent cobalamins and uses thereof
US6613516B1 (en) 1999-10-30 2003-09-02 Affymetrix, Inc. Preparation of nucleic acid samples
US20030175947A1 (en) * 2001-11-05 2003-09-18 Liu Robin Hui Enhanced mixing in microfluidic devices
US7312087B2 (en) 2000-01-11 2007-12-25 Clinical Micro Sensors, Inc. Devices and methods for biochip multiplexing
CN1654956A (en) * 2000-05-04 2005-08-17 耶鲁大学 High density protein arrays for screening of protein activity
US20060166227A1 (en) * 2000-06-20 2006-07-27 Stephen Kingsmore Protein expression profiling
US7892854B2 (en) * 2000-06-21 2011-02-22 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
US9709559B2 (en) 2000-06-21 2017-07-18 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
US6323009B1 (en) * 2000-06-28 2001-11-27 Molecular Staging, Inc. Multiply-primed amplification of nucleic acid sequences
WO2002002792A1 (en) 2000-06-30 2002-01-10 Molecular Staging, Inc. Signal amplification with lollipop probes
EP2100971A3 (en) * 2000-07-07 2009-11-25 Visigen Biotechnologies, Inc. Real-time sequence determination
US20070172866A1 (en) * 2000-07-07 2007-07-26 Susan Hardin Methods for sequence determination using depolymerizing agent
JP4382265B2 (en) * 2000-07-12 2009-12-09 キヤノンアネルバ株式会社 Forming method and forming device of the silicon oxide film
US20040185464A1 (en) * 2000-09-15 2004-09-23 Kris Richard M. High throughput assay system
US20040106109A1 (en) * 2001-10-02 2004-06-03 Belly Robert T Detection of ras mutations
US7211414B2 (en) 2000-12-01 2007-05-01 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
US6573051B2 (en) * 2001-03-09 2003-06-03 Molecular Staging, Inc. Open circle probes with intramolecular stem structures
CA2440754A1 (en) * 2001-03-12 2002-09-19 Stephen Quake Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension
US7262063B2 (en) 2001-06-21 2007-08-28 Bio Array Solutions, Ltd. Directed assembly of functional heterostructures
US20030022150A1 (en) * 2001-07-24 2003-01-30 Sampson Jeffrey R. Methods for detecting a target molecule
WO2003022769A9 (en) * 2001-09-07 2004-05-06 Penn State Res Found Modified substrates for the attachment of biomolecules
US6916541B2 (en) 2001-09-07 2005-07-12 Penn State Research Foundation Modified substrates for the attachment of biomolecules
CA2460981C (en) * 2001-09-24 2011-04-05 Arc Seibersdorf Research Gmbh Solid support for immobilizing biomolecules
DE10201463B4 (en) 2002-01-16 2005-07-21 Clondiag Chip Technologies Gmbh Reaction vessel for carrying out array method
US7553619B2 (en) * 2002-02-08 2009-06-30 Qiagen Gmbh Detection method using dissociated rolling circle amplification
US7166478B2 (en) * 2002-03-12 2007-01-23 Enzo Life Sciences, Inc., C/O Enzo Biochem, Inc. Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
US7579147B2 (en) 2002-05-07 2009-08-25 Wake Forest University Health Sciences Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease
US20040011650A1 (en) * 2002-07-22 2004-01-22 Frederic Zenhausern Method and apparatus for manipulating polarizable analytes via dielectrophoresis
JP3640388B2 (en) * 2002-10-29 2005-04-20 清春 大野 Method for producing labeled nucleic acids or proteins
US7526114B2 (en) 2002-11-15 2009-04-28 Bioarray Solutions Ltd. Analysis, secure access to, and transmission of array images
US9487823B2 (en) * 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification
US6977153B2 (en) * 2002-12-31 2005-12-20 Qiagen Gmbh Rolling circle amplification of RNA
US20090186343A1 (en) * 2003-01-28 2009-07-23 Visigen Biotechnologies, Inc. Methods for preparing modified biomolecules, modified biomolecules and methods for using same
WO2004092412A3 (en) 2003-03-31 2005-03-03 Roche Diagnostics Gmbh Compositions and methods for detecting certain flaviviruses, including members of the japanese encephalitis virus serogroup
US8043834B2 (en) 2003-03-31 2011-10-25 Qiagen Gmbh Universal reagents for rolling circle amplification and methods of use
US20050170367A1 (en) * 2003-06-10 2005-08-04 Quake Stephen R. Fluorescently labeled nucleoside triphosphates and analogs thereof for sequencing nucleic acids
US7927796B2 (en) * 2003-09-18 2011-04-19 Bioarray Solutions, Ltd. Number coding for identification of subtypes of coded types of solid phase carriers
EP1664722B1 (en) * 2003-09-22 2011-11-02 Bioarray Solutions Ltd Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules
WO2005045059A3 (en) * 2003-10-28 2005-09-09 Bioarray Solutions Ltd Allele assignment and probe selection in multiplexed assays of polymorphic targets
CA2899287A1 (en) 2003-10-28 2005-05-12 Bioarray Solutions Ltd. Optimization of gene expression analysis using immobilized capture probes
ES2533876T3 (en) 2003-10-29 2015-04-15 Bioarray Solutions Ltd Multiplexed analysis of nucleic acids by fragmentation dsDNA
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
WO2005054441A3 (en) * 2003-12-01 2006-11-09 California Inst Of Techn Device for immobilizing chemical and biomedical species and methods of using same
EP1716254B1 (en) 2004-02-19 2010-04-07 Helicos Biosciences Corporation Methods for analyzing polynucleotide sequences
US20060046258A1 (en) * 2004-02-27 2006-03-02 Lapidus Stanley N Applications of single molecule sequencing
US20050239085A1 (en) * 2004-04-23 2005-10-27 Buzby Philip R Methods for nucleic acid sequence determination
US7939251B2 (en) 2004-05-06 2011-05-10 Roche Molecular Systems, Inc. SENP1 as a marker for cancer
US7026851B2 (en) * 2004-05-12 2006-04-11 System General Corp. PWM controller having frequency jitter for power supplies
WO2006085898A1 (en) * 2004-05-14 2006-08-17 Becton, Dickinson & Company Articles having bioactive surfaces and solvent-free methods of preparation thereof
US20050260609A1 (en) * 2004-05-24 2005-11-24 Lapidus Stanley N Methods and devices for sequencing nucleic acids
US7635562B2 (en) * 2004-05-25 2009-12-22 Helicos Biosciences Corporation Methods and devices for nucleic acid sequence determination
US7363170B2 (en) * 2004-07-09 2008-04-22 Bio Array Solutions Ltd. Transfusion registry network providing real-time interaction between users and providers of genetically characterized blood products
US20060024678A1 (en) * 2004-07-28 2006-02-02 Helicos Biosciences Corporation Use of single-stranded nucleic acid binding proteins in sequencing
US7848889B2 (en) 2004-08-02 2010-12-07 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
CA2579150C (en) * 2004-09-17 2014-11-25 Pacific Biosciences Of California, Inc. Apparatus and method for analysis of molecules
US7170050B2 (en) * 2004-09-17 2007-01-30 Pacific Biosciences Of California, Inc. Apparatus and methods for optical analysis of molecules
US20060118754A1 (en) * 2004-12-08 2006-06-08 Lapen Daniel C Stabilizing a polyelectrolyte multilayer
US7220549B2 (en) 2004-12-30 2007-05-22 Helicos Biosciences Corporation Stabilizing a nucleic acid for nucleic acid sequencing
US20060172328A1 (en) * 2005-01-05 2006-08-03 Buzby Philip R Methods and compositions for correcting misincorporation in a nucleic acid synthesis reaction
US7482120B2 (en) * 2005-01-28 2009-01-27 Helicos Biosciences Corporation Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
US8309303B2 (en) * 2005-04-01 2012-11-13 Qiagen Gmbh Reverse transcription and amplification of RNA with simultaneous degradation of DNA
US20060263790A1 (en) * 2005-05-20 2006-11-23 Timothy Harris Methods for improving fidelity in a nucleic acid synthesis reaction
US8486629B2 (en) 2005-06-01 2013-07-16 Bioarray Solutions, Ltd. Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
EP1762627A1 (en) 2005-09-09 2007-03-14 Qiagen GmbH Method for the activation of a nucleic acid for performing a polymerase reaction
EP1934339B1 (en) * 2005-10-06 2011-12-14 Lucigen Corporation Thermostable viral polymerases and methods of use
US20070117102A1 (en) * 2005-11-22 2007-05-24 Buzby Philip R Nucleotide analogs
US20070117103A1 (en) * 2005-11-22 2007-05-24 Buzby Philip R Nucleotide analogs
US20070117104A1 (en) * 2005-11-22 2007-05-24 Buzby Philip R Nucleotide analogs
US20070128610A1 (en) * 2005-12-02 2007-06-07 Buzby Philip R Sample preparation method and apparatus for nucleic acid sequencing
US7476734B2 (en) * 2005-12-06 2009-01-13 Helicos Biosciences Corporation Nucleotide analogs
US20090305248A1 (en) * 2005-12-15 2009-12-10 Lander Eric G Methods for increasing accuracy of nucleic acid sequencing
US20080057499A1 (en) * 2006-02-06 2008-03-06 Affymetrix, Inc. Methods for high specificity whole genome amplification and hybridization
US7668697B2 (en) * 2006-02-06 2010-02-23 Andrei Volkov Method for analyzing dynamic detectable events at the single molecule level
US20080309926A1 (en) * 2006-03-08 2008-12-18 Aaron Weber Systems and methods for reducing detected intensity non uniformity in a laser beam
US7397546B2 (en) * 2006-03-08 2008-07-08 Helicos Biosciences Corporation Systems and methods for reducing detected intensity non-uniformity in a laser beam
DE102006020885A1 (en) * 2006-05-05 2007-11-08 Qiagen Gmbh Inserting a tag sequence into a nucleic acid comprises using an anchor oligonucleotide comprising a hybridizing anchor sequence and a nonhybridizing tag-template sequence
US20080241938A1 (en) * 2006-07-20 2008-10-02 Visigen Biotechnologies, Inc. Automated synthesis or sequencing apparatus and method for making and using same
US20080091005A1 (en) * 2006-07-20 2008-04-17 Visigen Biotechnologies, Inc. Modified nucleotides, methods for making and using same
US20080241951A1 (en) * 2006-07-20 2008-10-02 Visigen Biotechnologies, Inc. Method and apparatus for moving stage detection of single molecular events
US8815508B2 (en) 2008-08-12 2014-08-26 Zinfandel Pharmaceuticals, Inc. Method of identifying disease risk factors
US20110281359A1 (en) 2010-05-11 2011-11-17 Dow Agrosciences Llc Spnk strains
EP2520658B1 (en) 2011-05-03 2015-10-07 Dow AgroSciences LLC Enhancing spinosyn production with oxygen binding proteins
US9631195B2 (en) 2011-12-28 2017-04-25 Dow Agrosciences Llc Identification and characterization of the spinactin biosysnthesis gene cluster from spinosyn producing saccharopolyspora spinosa

Citations (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3669841A (en) 1970-02-11 1972-06-13 Monsanto Co Attachment of enzymes to siliceous materials
US3715278A (en) 1970-02-11 1973-02-06 Monsanto Co Enzyme-polymer product attached to surface of siliceous materials thereof
US3849137A (en) 1971-10-12 1974-11-19 Basf Ag Lithographic printing plates and photoresists comprising a photosensitive polymer
US3949064A (en) 1973-10-26 1976-04-06 Baxter Laboratories, Inc. Method of detecting antigens or antibodies
DE2618419A1 (en) 1975-04-28 1976-11-04 Miles Lab Heterogeneous specific binding method for determination of a ligand in a liquid medium and medium for carrying it out
US4001583A (en) 1974-10-04 1977-01-04 Barrett M James Covalently bound biological substances to plastic materials and use in radioassay
US4041146A (en) 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
US4059685A (en) 1973-03-19 1977-11-22 Summa Corporation Immobilized immunoadsorbent
DE2724486A1 (en) 1976-05-31 1977-12-22 Technion Res & Dev Foundation Heterogeneous specific binding method for determination of a ligand in a liquid medium and medium for carrying it out
US4106907A (en) 1976-02-13 1978-08-15 The Radiochemical Centre Limited Centrifuge tube and method for performing assay with same
US4116638A (en) 1977-03-03 1978-09-26 Warner-Lambert Company Immunoassay device
US4120945A (en) 1976-07-06 1978-10-17 Becton, Dickinson & Company Substrate coated with receptor and labeled ligand for assays
US4134792A (en) 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
US4166104A (en) 1976-11-19 1979-08-28 Ames-Yissum Ltd. Specific binding assay method and test kit employing polystyrene as separating agent
GB2014727A (en) 1978-02-14 1979-08-30 Sanyo Chemical Ind Ltd Immunologically active substance-glass conjugates process for producing the conjugates and diagnostic reagents comprising the conjugates
DE2915082A1 (en) 1978-04-13 1979-10-31 Pasteur Institut Method and reagent kit for the detection and characterization of nucleic acids and their sequences
GB2026690A (en) 1978-07-24 1980-02-06 Miles Lab Chemiluminescent-labeled conjugates for use in specific binding assays
US4228237A (en) 1978-09-21 1980-10-14 Calbiochem-Behring Corp. Methods for the detection and determination of ligands
US4230797A (en) 1975-04-28 1980-10-28 Miles Laboratories, Inc. Heterogenous specific binding assay employing a coenzyme as label
US4234681A (en) 1978-07-21 1980-11-18 The Regents Of The University Of California Immobolized light emitting systems
US4234563A (en) 1978-06-02 1980-11-18 American Hospital Supply Corporation Insolubilized deoxyribonucleic acid (DNA)
US4251514A (en) 1979-11-05 1981-02-17 American Hospital Supply Corporation Insolubilized deoxyribonucleic acid (DNA)
US4254097A (en) 1979-11-05 1981-03-03 American Hospital Supply Corporation Method of detecting antibodies to human thyroglobulin
US4261893A (en) 1975-04-28 1981-04-14 Miles Laboratories, Inc. Bis-phthalimide intermediates
US4269933A (en) 1978-06-08 1981-05-26 E. I. Du Pont De Nemours And Company Methods of developing photopolymerizable compositions containing an 0-nitroaromatic compound as photoinhibitor
US4271140A (en) 1978-01-23 1981-06-02 Baxter Travenol Laboratories, Inc. Method and composition for double receptor, specific binding assays
US4302204A (en) 1979-07-02 1981-11-24 The Board Of Trustees Of Leland Stanford Junior University Transfer and detection of nucleic acids
US4312944A (en) 1978-11-28 1982-01-26 Bo Gustav Mattiasson Carrying out assaying methods involving biospecific reactions
EP0046083A2 (en) 1980-08-11 1982-02-17 Minnesota Mining And Manufacturing Company Photolabile blocked surfactants and compositions containing the same
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4318981A (en) 1980-04-24 1982-03-09 Miles Laboratories, Inc. Homogeneous specific binding assay employing an intramolecularly modulated photogenic enzyme substrate label
US4318982A (en) 1979-06-04 1982-03-09 Miles Laboratories, Inc. FMN-Labeled specific binding assay
US4358535A (en) 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
EP0070687A2 (en) 1981-07-17 1983-01-26 Amoco Corporation Light-emitting polynucleotide hybridization diagnostic method
EP0070685A2 (en) 1981-07-17 1983-01-26 Amoco Corporation Homogeneous nucleic acid hybridization diagnostics by non-radiative energy transfer
US4374925A (en) 1978-11-24 1983-02-22 Syva Company Macromolecular environment control in specific receptor assays
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4380580A (en) 1978-04-10 1983-04-19 Miles Laboratories, Inc. Heterogenous chemiluminescent specific binding assay
US4383031A (en) 1975-04-28 1983-05-10 Miles Laboratories, Inc. Homogeneous chemiluminescent specific binding assay
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
WO1983002277A1 (en) 1981-12-29 1983-07-07 Kourilsky, Philippe Dna fragments marked at least at one of the ends thereof by modified ribonucleotides recognizable by related molecules and method for analyzing such dna fragments
WO1983002276A1 (en) 1981-12-29 1983-07-07 Kourilsky, Philippe Modified adenosine 5'-triphosphoric acid and method for dosing biological substances capable of fixing degradation products of adenosine 5'-triphosphoric acid
WO1983002286A1 (en) 1981-12-23 1983-07-07 Tchen, Paul Probe containing a modified nucleic acid recognizable by specific antibodies and utilization of said probe to test for and characterize an homologous dna sequence
GB2125946A (en) 1982-08-20 1984-03-14 Concentric Pumps Ltd Controlling a gerotor pump serving as a transmission coupling
EP0103197A1 (en) 1982-08-18 1984-03-21 E.I. Du Pont De Nemours And Company Acidic O-nitroaromatics as photoinhibitors of polymerization in positive working films
US4446231A (en) 1979-10-03 1984-05-01 Self Colin H Immunoassay using an amplified cyclic detection system
WO1984003564A1 (en) 1983-03-08 1984-09-13 Commw Serum Lab Commission Method of determining antigenically active amino acid sequences
US4483920A (en) 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
US4486539A (en) 1981-10-16 1984-12-04 Orioon Corporation Ltd. Detection of microbial nucleic acids by a one-step sandwich hybridization test
US4517338A (en) 1983-06-20 1985-05-14 Chiron Corporation Multiple reactor system and method for polynucleotide synthesis
US4516833A (en) 1982-12-27 1985-05-14 University Of Dayton Production of high performance optical spatial filters
US4537861A (en) 1983-02-03 1985-08-27 Elings Virgil B Apparatus and method for homogeneous immunoassay
US4542102A (en) 1983-07-05 1985-09-17 Molecular Diagnostics, Inc. Coupling of nucleic acids to solid support by photochemical methods
US4562157A (en) 1983-05-25 1985-12-31 National Research Development Corporation Diagnostic device incorporating a biochemical ligand
US4656127A (en) 1983-04-22 1987-04-07 Amersham International Plc. Method of detecting mutations in DNA and RNA
US4689405A (en) 1983-01-20 1987-08-25 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Process for the simultaneous synthesis of several oligonucleotides on a solid phase
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
US4713326A (en) 1983-07-05 1987-12-15 Molecular Diagnostics, Inc. Coupling of nucleic acids to solid support by photochemical methods
US4724202A (en) 1983-12-12 1988-02-09 Molecular Diagnostics, Inc. Use of non-hybridizable nucleic acids for the detection of nucleic acid hybridization
US4732847A (en) * 1981-06-09 1988-03-22 University Of Hawaii Monoclonal antibodies for DNA-RNA hybrid complexes and their uses
US4824776A (en) 1985-07-25 1989-04-25 Molecular Biosystems, Inc. Method for increasing the sensitivity of nucleic acid hybridization assays
EP0063879B1 (en) 1981-04-17 1989-11-23 Yale University Modified nucleotides and methods of preparing and using same
US4973493A (en) 1982-09-29 1990-11-27 Bio-Metric Systems, Inc. Method of improving the biocompatibility of solid surfaces
US4994373A (en) * 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
EP0097373B1 (en) 1982-06-23 1992-10-07 Enzo Biochem, Inc. Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same
US5241060A (en) 1982-06-23 1993-08-31 Enzo Diagnostics, Inc. Base moiety-labeled detectable nucleatide
US5260433A (en) 1982-06-23 1993-11-09 Enzo Diagnostics, Inc. Saccharide specific binding system labeled nucleotides
JP2825090B2 (en) 1983-01-27 1998-11-18 エンゾー バイオケム,インコーポレイティド Kits useful for nucleic acid detection, a method for determining the presence of genetic material, and soluble signals colorimetric or optically detectable or apparatus for measuring

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652761A (en) * 1969-09-04 1972-03-28 Corning Glass Works Immunochemical composites and antigen or antibody purification therewith

Patent Citations (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3715278A (en) 1970-02-11 1973-02-06 Monsanto Co Enzyme-polymer product attached to surface of siliceous materials thereof
US3669841A (en) 1970-02-11 1972-06-13 Monsanto Co Attachment of enzymes to siliceous materials
US3849137A (en) 1971-10-12 1974-11-19 Basf Ag Lithographic printing plates and photoresists comprising a photosensitive polymer
US4059685A (en) 1973-03-19 1977-11-22 Summa Corporation Immobilized immunoadsorbent
US3949064A (en) 1973-10-26 1976-04-06 Baxter Laboratories, Inc. Method of detecting antigens or antibodies
US4001583A (en) 1974-10-04 1977-01-04 Barrett M James Covalently bound biological substances to plastic materials and use in radioassay
GB1548741A (en) 1975-04-28 1979-07-18 Miles Lab Heterogenous specific binding assay method and test systemfor use therein
US4230797A (en) 1975-04-28 1980-10-28 Miles Laboratories, Inc. Heterogenous specific binding assay employing a coenzyme as label
US4383031A (en) 1975-04-28 1983-05-10 Miles Laboratories, Inc. Homogeneous chemiluminescent specific binding assay
GB1552607A (en) 1975-04-28 1979-09-19 Miles Lab Homogenous specific binding assay method and test system for use therein
DE2618419A1 (en) 1975-04-28 1976-11-04 Miles Lab Heterogeneous specific binding method for determination of a ligand in a liquid medium and medium for carrying it out
US4261893A (en) 1975-04-28 1981-04-14 Miles Laboratories, Inc. Bis-phthalimide intermediates
US4041146A (en) 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
US4106907A (en) 1976-02-13 1978-08-15 The Radiochemical Centre Limited Centrifuge tube and method for performing assay with same
DE2724486A1 (en) 1976-05-31 1977-12-22 Technion Res & Dev Foundation Heterogeneous specific binding method for determination of a ligand in a liquid medium and medium for carrying it out
US4120945A (en) 1976-07-06 1978-10-17 Becton, Dickinson & Company Substrate coated with receptor and labeled ligand for assays
US4166104A (en) 1976-11-19 1979-08-28 Ames-Yissum Ltd. Specific binding assay method and test kit employing polystyrene as separating agent
US4166103A (en) 1976-11-19 1979-08-28 Ames-Yissum Ltd. Specific binding assay method and test kit employing polyvinyl alcohol as separating agent
US4134792A (en) 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
US4116638A (en) 1977-03-03 1978-09-26 Warner-Lambert Company Immunoassay device
US4271140A (en) 1978-01-23 1981-06-02 Baxter Travenol Laboratories, Inc. Method and composition for double receptor, specific binding assays
GB2014727A (en) 1978-02-14 1979-08-30 Sanyo Chemical Ind Ltd Immunologically active substance-glass conjugates process for producing the conjugates and diagnostic reagents comprising the conjugates
US4280992A (en) 1978-02-14 1981-07-28 Sanyo Chemical Industries, Ltd. Immunologically active substance-glass conjugates, process for producing the same and diagnostic reagents containing the same
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4380580A (en) 1978-04-10 1983-04-19 Miles Laboratories, Inc. Heterogenous chemiluminescent specific binding assay
DE2915082A1 (en) 1978-04-13 1979-10-31 Pasteur Institut Method and reagent kit for the detection and characterization of nucleic acids and their sequences
US4581333A (en) 1978-04-13 1986-04-08 Institut Pasteur Method of detecting and characterizing a nucleic acid or reactant for the application of this method
GB2019408A (en) 1978-04-13 1979-10-31 Pasteur Institut Method of detecting and characterizing a nucleic acid or a sequence of the latter and enzymatic reactant for the application of this method
US4234563A (en) 1978-06-02 1980-11-18 American Hospital Supply Corporation Insolubilized deoxyribonucleic acid (DNA)
US4269933A (en) 1978-06-08 1981-05-26 E. I. Du Pont De Nemours And Company Methods of developing photopolymerizable compositions containing an 0-nitroaromatic compound as photoinhibitor
US4234681A (en) 1978-07-21 1980-11-18 The Regents Of The University Of California Immobolized light emitting systems
GB2045239A (en) 1978-07-24 1980-10-29 Miles Lab Intermediates useful in the synthesis of chemiluminescent- labeled conjugates for use in specific binding assays
GB2041922A (en) 1978-07-24 1980-09-17 Miles Lab Intermediates useful in the synthesis of chemiluminescent- labeled conjugates for use in specific binding assays
GB2026690A (en) 1978-07-24 1980-02-06 Miles Lab Chemiluminescent-labeled conjugates for use in specific binding assays
US4228237A (en) 1978-09-21 1980-10-14 Calbiochem-Behring Corp. Methods for the detection and determination of ligands
US4374925A (en) 1978-11-24 1983-02-22 Syva Company Macromolecular environment control in specific receptor assays
US4312944A (en) 1978-11-28 1982-01-26 Bo Gustav Mattiasson Carrying out assaying methods involving biospecific reactions
US4318982A (en) 1979-06-04 1982-03-09 Miles Laboratories, Inc. FMN-Labeled specific binding assay
US4302204A (en) 1979-07-02 1981-11-24 The Board Of Trustees Of Leland Stanford Junior University Transfer and detection of nucleic acids
US4446231A (en) 1979-10-03 1984-05-01 Self Colin H Immunoassay using an amplified cyclic detection system
US4251514A (en) 1979-11-05 1981-02-17 American Hospital Supply Corporation Insolubilized deoxyribonucleic acid (DNA)
US4254097A (en) 1979-11-05 1981-03-03 American Hospital Supply Corporation Method of detecting antibodies to human thyroglobulin
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4318981A (en) 1980-04-24 1982-03-09 Miles Laboratories, Inc. Homogeneous specific binding assay employing an intramolecularly modulated photogenic enzyme substrate label
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
EP0046083A2 (en) 1980-08-11 1982-02-17 Minnesota Mining And Manufacturing Company Photolabile blocked surfactants and compositions containing the same
US4358535A (en) 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4358535B1 (en) 1980-12-08 1986-05-13
US5449767A (en) 1981-04-17 1995-09-12 Yale University Modified polynucleotides and methods of preparing same
US5328824A (en) 1981-04-17 1994-07-12 Yale University Methods of using labeled nucleotides
EP0063879B1 (en) 1981-04-17 1989-11-23 Yale University Modified nucleotides and methods of preparing and using same
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
US5476928A (en) 1981-04-17 1995-12-19 Yale University Modified nucleotides and polynucleotides and complexes form therefrom
US4732847A (en) * 1981-06-09 1988-03-22 University Of Hawaii Monoclonal antibodies for DNA-RNA hybrid complexes and their uses
EP0070687A2 (en) 1981-07-17 1983-01-26 Amoco Corporation Light-emitting polynucleotide hybridization diagnostic method
EP0070685A2 (en) 1981-07-17 1983-01-26 Amoco Corporation Homogeneous nucleic acid hybridization diagnostics by non-radiative energy transfer
US4563419A (en) 1981-10-16 1986-01-07 Orion Corporation Ltd. Detection of microbial nucleic acids by a one-step sandwich hybridization test
US4486539A (en) 1981-10-16 1984-12-04 Orioon Corporation Ltd. Detection of microbial nucleic acids by a one-step sandwich hybridization test
WO1983002286A1 (en) 1981-12-23 1983-07-07 Tchen, Paul Probe containing a modified nucleic acid recognizable by specific antibodies and utilization of said probe to test for and characterize an homologous dna sequence
US5098825A (en) 1981-12-23 1992-03-24 Institut Pasteur Probe containing a modified nucleic acid recognizable by specific antibodies and use of this probe to detect and characterize a homologous dna sequence
WO1983002277A1 (en) 1981-12-29 1983-07-07 Kourilsky, Philippe Dna fragments marked at least at one of the ends thereof by modified ribonucleotides recognizable by related molecules and method for analyzing such dna fragments
WO1983002276A1 (en) 1981-12-29 1983-07-07 Kourilsky, Philippe Modified adenosine 5'-triphosphoric acid and method for dosing biological substances capable of fixing degradation products of adenosine 5'-triphosphoric acid
US4483920A (en) 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
US5260433A (en) 1982-06-23 1993-11-09 Enzo Diagnostics, Inc. Saccharide specific binding system labeled nucleotides
US5241060A (en) 1982-06-23 1993-08-31 Enzo Diagnostics, Inc. Base moiety-labeled detectable nucleatide
EP0097373B1 (en) 1982-06-23 1992-10-07 Enzo Biochem, Inc. Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same
EP0103197A1 (en) 1982-08-18 1984-03-21 E.I. Du Pont De Nemours And Company Acidic O-nitroaromatics as photoinhibitors of polymerization in positive working films
GB2125946A (en) 1982-08-20 1984-03-14 Concentric Pumps Ltd Controlling a gerotor pump serving as a transmission coupling
US4973493A (en) 1982-09-29 1990-11-27 Bio-Metric Systems, Inc. Method of improving the biocompatibility of solid surfaces
US4516833A (en) 1982-12-27 1985-05-14 University Of Dayton Production of high performance optical spatial filters
US4689405A (en) 1983-01-20 1987-08-25 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Process for the simultaneous synthesis of several oligonucleotides on a solid phase
US4994373A (en) * 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
JP2825090B2 (en) 1983-01-27 1998-11-18 エンゾー バイオケム,インコーポレイティド Kits useful for nucleic acid detection, a method for determining the presence of genetic material, and soluble signals colorimetric or optically detectable or apparatus for measuring
US4537861A (en) 1983-02-03 1985-08-27 Elings Virgil B Apparatus and method for homogeneous immunoassay
WO1984003564A1 (en) 1983-03-08 1984-09-13 Commw Serum Lab Commission Method of determining antigenically active amino acid sequences
US4656127A (en) 1983-04-22 1987-04-07 Amersham International Plc. Method of detecting mutations in DNA and RNA
US4562157A (en) 1983-05-25 1985-12-31 National Research Development Corporation Diagnostic device incorporating a biochemical ligand
US4517338A (en) 1983-06-20 1985-05-14 Chiron Corporation Multiple reactor system and method for polynucleotide synthesis
US4542102A (en) 1983-07-05 1985-09-17 Molecular Diagnostics, Inc. Coupling of nucleic acids to solid support by photochemical methods
US4713326A (en) 1983-07-05 1987-12-15 Molecular Diagnostics, Inc. Coupling of nucleic acids to solid support by photochemical methods
US4724202A (en) 1983-12-12 1988-02-09 Molecular Diagnostics, Inc. Use of non-hybridizable nucleic acids for the detection of nucleic acid hybridization
US4824776A (en) 1985-07-25 1989-04-25 Molecular Biosystems, Inc. Method for increasing the sensitivity of nucleic acid hybridization assays

Non-Patent Citations (99)

* Cited by examiner, † Cited by third party
Title
"Diagnostic Immunology: Current and Future Trends," Cap Conference, Aspen, 1978, p. 67 and 80.
Alberts et al., Molecular Biology of the Cell, Garland Publishers, New York and London (1983), p. 719.
Amit B. et al., Israel Journal of Chemistry 12(1-2): 103-113 (1974).
Amit B. et al., Journal of Organic Chemistry 39(2): 192-196 (1974).
Avrameas and Guilbert," Enzyme-immunoassay for the measurement of antigens using peroxidase conjugates," Biochimie 54: 837-842 (1972).
Avrameas et al., "Enzyme immunoassay for the measurement of antigens using peroxidase conjugates," Biochemie 54:837-842 (1972).
Barltrop J.A. et al., Chemical Communications 22:822-823 (1966).
Bauman et al., "A new method for fluorescence microscopical localization of specific DNA sequences by in situ hybridization of fluorochrome-labelled RNA," Exp. Cell Res. 128:485-490 (1980).
Bauman et al., "Rapid and High Resolution Detection of in situ Hybridization to Polytene Chromosomes Using Fluorochrome-Labeled RNA." Chromosoma (Berl.) 84: 1-18 (1981).
Beltz G.A. et al., Methods in Enzymology 100:266-285 (1983).
Benton, W.D. and David, R.W., "Screening Agt recombinant clones by hybridization to single plaques in situ," Science 196: 180 (1977).
Bergstrom et al., "C-5 Substituted Pyrimidine Nucleosides.2.Synthesis, via Olefin Coupling to Organopalladium Intermediates Derived from Uridine and 2'-Deoxyuridine," J. Amer. Chem. Soc. 100(26):8106-8112 (1978).
Bigge et al., "Palladium-Catalyzed Coupling Reactions of Uracil Nucleosides and Nucleotides," J. Amer. Chem. Soc. 102:2033 (1980).
Bildwell et al., "Enzyme Immunoassays for Viral Diseases," J. Infectious Disease: 136: S274-S278 (1977).
Broker et al., "Electron Microscopic Visualization of tRNA genes with Ferritin-Avidin: Biotin Labels," Nucl. Acids Res., 5(2): 363-384 (1978).
Bunemann H. et al., Nucleic Acids Research 10(22):7163-7180 (1982).
Bunemann H., Nucleic Acids Research 10(22):7181-7196 (1982).
Buongiorno-Nardelli, M. and Amaldi, F., Autoradiographic Detection of Molecular Hybrids Between rRNA and DNA in Tissue Sections, Nature, vol. 225, Mar. 7, 1970.
Calva E. et al., The Journal of Biological Chemistry 255(22):11011-11016 (1980).
Chard T., An Introduction To Radioimmunoassay And Related Techniques, Elsevier Science Publishers, B.V. (1978).
Coffin J.M. et al., Cell 13:761-773 (1978).
Dallas and Falkow, "Molecular and Genetic Analysis of a DNA sequence Encoding for Enterotoxin Synthesis in Escherichia coli," Thriteenth Joint Conference on Cholera, The U.S.-Japan Cooperative Medical Science Program (1977).
Dallas et al. "The Characterization of an Escherichia coli Plasmid Determinant That Encodes for the Production of a Heat-Labile Enterotoxin," Plasmids of Medical Environmental and Commercial Importance, K.N. Timmis and A. Puhler, editors, Elservier/North-Holland Biomedical Press (1979).
Dictionary of Biochemistry, Tokyo Kagaku Doujin, 1984, pp. 727, 507, 450 and one other page.
Elisa: In The Clinical Microbiology Laboratory, ed. T. G. Wreghitt and P. Morgan-Capner, Chapter 1, p. 9, 1990.
English Translation for Dictionary of Biochemistry, Tokyo Kagaku Doujin, 1984,pp. 727, 507, 450 and one other page.
English Translation for Method in Nucleic Acid Research, "DNA-DNA Hybridization", Kyoritsu Shuppan Co., Ltd., 1973, pp. 60-67 and 242.
Engvall and Perlmann, "Enzyme-linked immunosorbent assay (ELISA) Quantitative assay of immunoglobulin G," Immunochem 8: 871-874 (1971).
Fertel R. and Weiss, B., "Measurement of the Activity of Cyclic Nucleotide Phosphodiesterases with Firefly Luciferin-Luciferase Coupled Assay Systems," Methods in Enzymol. vol. LVII, Bioluminescence and Chemiluminescnece, DeLuca, M.A. (Ed.) 94-96 (1978).
Fertel R. and Weiss, B., Methods in Enzymol. vol. LV II, Bioluminescence and Chemiluminescnece, DeLuca, M.A. (Ed.) 94-106 (1978).
Filippusson et al., "The Preparation and Properties of Yeast beta-Fructofuranosidase," Biochem J. 120:215-219 (1970).
Flanders D.C. and Smith, H.I., Applied Physics Letters 31(7):426-428 (1977).
Frank R. et al., Nucleic Acids Research 11(13):4365-4377 (1983).
Grunstein, M., "Colony Hybridization: A Method For The Isolation of Cloned DNAs That Contain A Specific Gene," Proc. Natl. Acad. Sci. (USA) 72:3961-3965 (1975).
Guesdon et al., "The Use of Avidin-Biotin Interaction in Immunoenzymatic Techniques," Journal of Histochemistry and Cytochemistry 27(8):1131-1139 (1979).
Hamaguchi et al., "Enzyme-Linked Sandwich Immunoassay of Macromolecular Antigens Using the Rabbit Antibody-Coupled Glass Rod as a Solid Phase," Eur. J. Biochem. 7: 459-467 (1976) and FEBS Letters: 69(1): 11-14 (1976).
Haugen et al., Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay, PNAS, 78, pp. 4124-4127 (1981).
Hofmann et al., "Characterization of the Functional Groups of Bioten", J. Biol. Chem., 141, 207-11 (1941).
Hofmann et al., "Iminobiotin Affinity Columns and Their Application to Retrieval of Streptavidin", Proc. Natl. Acad. Sci. USA, 77, No. 8, pp. 4666-4668 (1980).
Hood et al., Immunology, Benjamin/Cummings Publishing Co., Inc. Menlo Park, CA (1978), p. 142.
Huang and Pagano, "Nucleic Acid Hybridization Technology and Detection of Proviral Genomes," Methods in Virology., 6: 457-97 (1977).
John et al., "RNA-DNA Hybrids at the Cytological Level," Nature 223: 582-587 (1969).
Joseph Gall and Mary Lou Perdue, Formation and Detection of RNA-DNA Hybrid Molecules in Cytological Preparations, Genetics, 63: 378-383, Mar. 1969.
Kafatos F.C et al., Nucleic Acids Research 7(6): 1541-1552 (1979).
Kennell, "Principles and Practices of Nucleic Acid Hybridization," Progr. Nuc. Acid. Res. Mol. Biol., vol. 11, pp. 259-262 (1971).
Kochetkov, N.K. et al., Organic Chemistry of Nucleic Acids, Part B, Kochetkov, N.K., and Budovskii, E.I. (Eds.): 331-332 (1972).
Krile T.F. et al., Applied Optics 18(1):52-56 (1979).
Land, D.B. and Jackim, E., "A New Fluorescence-Yielding Substrate for Alkaline and Acid Phosphatase," Analytical Biochemistry, 16: 481-486 (1966).
Landreth K.S. et al., roc.Natl.Acad.Sci (USA) 79:2370-2374 (1982).
Langer and Ward, "A Rapid and Sensitive Immunological Method for In Situ Gene Mapping," in Developmental Biology Using Purified Genes, ed. D.D. Brown, Academic Press, pp. 647-658 (1981).
Langer and Ward, Abstract 1153: A Rapid and Sensitive Immunological Method for In Situ Gene Mapping in Journal of Supramolecular Structure and Cellular Biology, (1981).
Langer et al., "Enzymatic Synthesis of Biotin-Labeled Polynucleotides: Novel Nucleic Acid Affinity Probes," Proc. Natl. Acad. Sci. (USA), 78 (11):6633-6637 (Nov. 1981).
Langer-Sofer et al., "Immunological method for mapping genes on Drosophila polytene chromosomes," Proc. Natl. Acad. Sci. (USA) 79:4381-4385 (Jul. 1982).
Leary, Brigati and Ward, "Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots," Proc. Natl. Acad. Sci (USA) 80: 4045-4049 (Jul. 1983).
Mage M.G. et al, Journal of Immunological Methods 15:47-56 (1977).
Manning J. et al., Biochemistry 16(7): 1364-1370 (1977).
Manning J.E. et al., Chromosoma (Berl.) 53:107-117 (1975).
Manuelidis et al. (1982) Journal of Cell Biology, vol. 95, pp. 619-625. *
Masiakowski P. et al., Nucleic Acids Research 10(24):7895-7903 (1982).
Mathews, J.C. and Cormier, M.J., "Rapid Microassay for the Calcium-Dependent Protein Modulator of Cyclic Nucleotide Phosphodiesterase," Methods in Enzymol. vol. LV II, Bioluminescence and Chemiluminescnece, DeLuca, M.A. (Ed.) 107-108 (1978).
Maxam, A.M. and Gilbert, W., Methods in Enzymology 65:499-560 (1980).
Mesulam, M. M. and Rosene, D.L., "Sensitivity in Horseradish Peroxidase Neurohistochemistry: A Comparative Study of Nine Methods," J. Histochem. Cytochem. 27: No. 3, pp. 763-778 (1979).
Method in Nucleic Acid Research, "DNA-DNA Hybridization", Kyoritsu Shuppan Co., Ltd., 1973, pp. 60-67 and 242.
Miranda, Q.R:, et al., "Solid-Phase Enzyme Immunoassay for Herpes Simplex Virus," J. Infectious Disease 136: S304-S310 (Oct., 1977).
Mosback, K., et al., "immobilized Coenzymes," Methods in Enzymology, vol. XLIV: 859-887 (1976).
Munns and Liszewski, "Antibodies specific for Modified Nucleosides et al.," Progr. Nucl. Acid Res. & Molec. Bio., Academic Press, Inc., vol. 24, pp. 109-165 (1980).
Nagata et al., "Quantification of picogram levels of specific DNA immobilized in microtiter wells," FEBS, 183, pp. 379-382 (Apr. 1985).
Nishimura et al. "Synthetic Nucleosides and Nucleotides: 5-Dimethylamino-2-oxidoisoquinolin-1 yl Diazomethane: A Novel Water Soluble Fluorescent Labelling Agent for Nucleotides," Chem. Pharm. Bull., 28(6): 1695-1703 (1980).
Ohtsuka E. et al., Nucleic Acids Research 1(10):1351-1357 (1974).
Patchornik A. and Amit B., Journal of the American Chemical Society 92:6333-6335 (1970).
Pillai V.N.R., Synthesis (International Journal of Methods in Synthetic Organic Chemistry Chemistry), Schill, G. et al., eds., Georg Thieme Verlag publishers, Stuttgart and New York, pp. 1-26, published 1980.
Reiser et al., "Transfer of Small DNA Fragments from Polyacrylamide Gels to Diazobenzyloxymethyl-paper and Detection by Hybridization with DNA Probes," Biochem. And Biophys. Res. Comm., 85, No. 3, pp. 1104-1112 (1978).
Rosswell, D.F. and White E.H., "The Chemiluminescence of Luminol and Related Hydrazides" in Methods in Enzymol. vol. LV II, Bioluminescence and Chemiluminescnece, DeLuca, M.A. (Ed.) 409-423 (1978).
Rudkin and Stollar, "High Resolution Detection of DNA-RNA Hybrids in situ by Indirect Immunofluorescence," Nature, 265: 472-73 (1977).
Ruth et al., "C-5 Substituted Pyrimidine Nucleosides. 1.Synthesis of C-5 Allyl, Propyl, and Propenyl Uracil and Cytosine Nucleosides via Organopalladium Intermediates," J. Org. Chem. 43(14):2870-2876 (1978).
Sanger, F. et al., Proc. Natl. Acad. Sci (USA) 74(12):5463-5467 (1977).
Schott, H., et al., "A Dihydroxyboryl-Substituted Methacrylic Polymer for the Column Chromatographic Separation of Mononucleotides, Oligonucleotides, and Transfer Ribonucleic Acid," Biochemistry 12: 932-937 (1973).
Schuurs et al., "Enzyme Immunoassay," Clinica Chimica Acta 81:1-40 (1977).
Sedlacek, H. et al., A New Method for Fluorescence Immunoassay Using Plane Surface Solid Phases (FIAPS), J. Immun. Methods, 26, (1979) 11-24.
Seed B., Nucleic Acids Research 10(5):1799-1810 (1982).
Sim G.K. et al., Cell 18:1303-1316 (1979).
Singer et al., "Actin Gene Expression Visualized In Chicken Muscle Tissue Culture by Using In Situ Hybridization With A Biotinated Nucleotide Analog," Proc. Nat'l Acad. Sci (USA) 79:7331-7335 (1982).
So, et al., "Characterization of an Escherichia coli Plasmid Encoding for the Synthesis of Heat-Labile Toxin: Molecular Cloning of the Toxin Determinant", Infection and Immunity, 21: 405-11(1978).
Sodja and Davidson, "Gene Mapping and Gene Enrichment by the Avidin-Biotin Interaction: Use of Cytochrome-C as a Polyamine Bridge," Nucl. Acids. Res, 5, pp. 385-400 (1978).
Stavrianopoulos et al., "Glycosylated DNA Probes For Hybridization/ Detection of Homologous Sequences," presented at the Third Annual Congress For Recombinant DNA Research (1983).
Stuart, W.D., et al., "Location of the 18/28S ribosomal RNA genes in two Hawaiian Drosophila species by monoclonal immunological identification of RNA-DNA hybrids in situ," Proc. Natl. Acad. Sci. USA 78:3751-3754 (1981).
Szostak et al., "Hybridization with Synthetic Oligonucleotides," Methods in Enzymol. 68: 419-429 (1979).
Towbin H. et al., "Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications," Proc. Natl. Acad. Sci (USA) 76: 4350-4354 (1979).
Ueda R. et al., Serological Analysis of Cell Surface Antigens of Null Cell Acute Lymphocytic Leukemia by et al., Proc. Natl. Acad. Sci. USA, vol. 79, pp. 4386-4390, Jul. 1982.
Van Der Laken et al., "Measurement of O6-ethyldeoxyguanosine and N-(deoxyguanosin-8-yl)-N-acetyl-2-aminofluorene in DNA et al.," Carcinogenesis, 3, 569-572 (1982).
Van Weemen and Schuurs, "Immunoassay Using Antigen-Enzyme Conjugates," FEBS Letters 15, No. 3: 232-236 (1971).
Vogelstein, B. and Gillespie, D., Preparative and Analytical Purification of DNA From Agarosa, Proc. Natl. Acad. Sci. USA vol. 76, No. 2, pp. 615-619, Feb. 1979.
Voller et al., "A microplate method of enzyme-linked immunosorbent assay and its application to malaria," Bull, W.H.O., 51: 209-211 (1974).
Voller et al., "Enzyme immunoassays with special reference to ELISA techniques," J. Clinical Pathology, 31: 507-520 (1978).
Weetal et al., "Porous Glass for Affinity Chromatography Applications," Methods in Enzymology, vol. 34, Affinity Techniques Enzyme Purification: Part B, pp. 59-72 (Jakoby, W.B. and Wilchek, M., eds.) (1974).
Weissback, A., and Poonian, M., "Nucleic Acids Attached to Solid Matrices," Methods in Enzymology, vol. XXXIV, Part B: 463-475 (1974).
Wengler G. et al., Virology 78:124-134 (1977).
Wysocki L.J. and Sato, V.L., Proc.Natl.Acad.Sci (USA) 75(6):2844-2848 (Jun. 1978).
Zehavi U. et al., Journal of Organic Chemistry 37(14):2281-2285 (1972).

Cited By (204)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100130368A1 (en) * 1998-07-30 2010-05-27 Shankar Balasubramanian Method and system for sequencing polynucleotides
US20040106110A1 (en) * 1998-07-30 2004-06-03 Solexa, Ltd. Preparation of polynucleotide arrays
US9434984B2 (en) 2001-06-30 2016-09-06 Enzo Life Sciences, Inc. Composition comprising an array which further comprises chimeric compositions
US20050233343A1 (en) * 2001-06-30 2005-10-20 Enzo Life Sciences Inc., Composition of matter comprising library of analytes hybridized to nucleic acid array for generating complex formation and signaling domains
US20060014156A1 (en) * 2001-06-30 2006-01-19 Enzo Life Sciences, Inc. Nucleic acid detecting or quantifying processes
US20060035238A1 (en) * 2001-06-30 2006-02-16 Enzo Life Sciences, Inc. Composition comprising an array which further comprises chimeric compositions
US20060040272A1 (en) * 2001-06-30 2006-02-23 Enzo Life Sciences, Inc., C/O Enzo Biochem, Inc. Composition comprising library of double stranded nucleic acids
US20060040271A1 (en) * 2001-06-30 2006-02-23 Enzo Life Sciences, Inc. Processes for detecting or quantifying more than one nucleic acid in a library
US20060040270A1 (en) * 2001-06-30 2006-02-23 Enzo Life Sciences, Inc. Processes for detecting or quantifying more than one nucleic acid in library
US20060057583A1 (en) * 2001-06-30 2006-03-16 Elazar Rabbani Novel compositions and methods for controlling the extendability of various components used in copying or amplification steps
US20060099601A1 (en) * 2001-06-30 2006-05-11 Enzo Life Sciences, Inc., Novel compositions and processes for analyte detection, quantification and amplification
US20060172310A1 (en) * 2001-06-30 2006-08-03 Enzo Life Sciences, Inc., C/O Enzo Biochem, Inc. Detection and quantification process for more than one nucleic acid in library
US20060257906A1 (en) * 2001-06-30 2006-11-16 Enzo Life Sciences, Inc. Compositions comprising a library of analytes for detection, quantification and analyses
US20050202455A1 (en) * 2001-06-30 2005-09-15 Enzo Life Sciences, Inc. Process for producing two or more copies of nucleic acids in a library, and process for detecting or quantifiying more than one nucleic acid in a library
US8597888B2 (en) 2001-06-30 2013-12-03 Enzo Life Sciences, Inc. Processes for detecting or quantifying more than one nucleic acid in a library
US8557522B2 (en) 2001-06-30 2013-10-15 Enzo Life Sciences, Inc. Processes for detecting or quantifying more than one nucleic acid in library
US9777406B2 (en) 2001-06-30 2017-10-03 Enzo Biochem, Inc. Process for detecting or quantifying nucleic acids in a library
US9163280B2 (en) 2001-06-30 2015-10-20 Enzo Life Sciences, Inc. Process for detecting or quantifying nucleic acids in a library
US9234235B2 (en) 2001-06-30 2016-01-12 Enzo Life Sciences, Inc. Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids
US9873956B2 (en) 2001-06-30 2018-01-23 Enzo Biochem, Inc. Compositions and processes for analyte detection, quantification and amplification
US9790621B2 (en) * 2001-06-30 2017-10-17 Enzo Life Sciences, Inc. Composition of matter comprising library of first nucleic acid analyte copies
US9765387B2 (en) 2001-06-30 2017-09-19 Enzo Biochem, Inc. Process for detecting or quantifying nucleic acids in a library
US20070281863A1 (en) * 2001-06-30 2007-12-06 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US9234234B2 (en) 2001-06-30 2016-01-12 Enzo Life Sciences, Inc. Detection and quantification process for more than one nucleic acid in library
US20050009077A1 (en) * 2001-06-30 2005-01-13 Enzo Life Sciences Inc., Composition of matter comprising library of first nucleic acid analyte copies
US9487821B2 (en) 2001-06-30 2016-11-08 Enzo Life Sciences, Inc. Composition comprising library of double stranded nucleic acids
US9745619B2 (en) 2001-06-30 2017-08-29 Enzo Biochem, Inc. Process for detecting or quantifying nucleic acids in a library
US9650666B2 (en) 2001-06-30 2017-05-16 Enzo Biochem, Inc. Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids
US9279147B2 (en) 2001-06-30 2016-03-08 Enzo Life Sciences, Inc. Processes for detecting or quantifying analytes of interest
US9309563B2 (en) 2001-06-30 2016-04-12 Enzo Life Sciences, Inc. Compositions and processes for analyte detection, quantification and amplification
US9771667B2 (en) 2001-06-30 2017-09-26 Enzo Life Sciences, Inc. Arrays comprising chimeric compositions
US9637778B2 (en) 2001-06-30 2017-05-02 Enzo Biochem, Inc. Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids
US9617585B2 (en) 2001-06-30 2017-04-11 Enzo Life Sciences, Inc. Processes for detecting or quantifying more than one nucleic acid in a library
US9617584B2 (en) 2001-06-30 2017-04-11 Enzo Biochem, Inc. Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids
US9611508B2 (en) 2001-06-30 2017-04-04 Enzo Life Sciences, Inc. Processes for detecting or quantifying nucleic acids in a library
US9528146B2 (en) 2001-06-30 2016-12-27 Enzo Life Sciences, Inc. Processes for detecting or quantifying more than one nucleic acid in a library
US9057100B2 (en) 2001-06-30 2015-06-16 Enzo Life Sciences, Inc. Composition comprising array of nucleic acid primer sets
US7807352B2 (en) 2001-06-30 2010-10-05 Enzo Life Sciences, Inc. Process for producing two or more copies of nucleic acids in a library, and process for detecting or quantifiying more than one nucleic acid in a library
US9428797B2 (en) 2001-06-30 2016-08-30 Enzo Life Sciences, Inc. Nucleic acid detecting or quantifying processes
US9316587B2 (en) 2002-03-12 2016-04-19 Enzo Life Sciences, Inc. Processes for quantitative or qualitative detection of single-stranded or double-stranded nucleic acids
US9068948B2 (en) 2002-03-12 2015-06-30 Enzo Life Sciences, Inc. Processes for detection of nucleic acids
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US8105771B2 (en) 2003-02-26 2012-01-31 Callida Genomics, Inc. Random array DNA analysis by hybridization
US8785127B2 (en) 2003-02-26 2014-07-22 Callida Genomics, Inc. Random array DNA analysis by hybridization
US20090036316A1 (en) * 2003-02-26 2009-02-05 Complete Genomics, Inc. Random array DNA analysis by hybridization
US7910304B2 (en) 2003-02-26 2011-03-22 Callida Genomics, Inc. Random array DNA analysis by hybridization
US20090011416A1 (en) * 2003-02-26 2009-01-08 Complete Genomics, Inc. Random array DNA analysis by hybridization
US20090005259A1 (en) * 2003-02-26 2009-01-01 Complete Genomics, Inc. Random array DNA analysis by hybridization
US20070037152A1 (en) * 2003-02-26 2007-02-15 Drmanac Radoje T Random array dna analysis by hybridization
US7906285B2 (en) 2003-02-26 2011-03-15 Callida Genomics, Inc. Random array DNA analysis by hybridization
US8278039B2 (en) 2003-02-26 2012-10-02 Complete Genomics, Inc. Random array DNA analysis by hybridization
US8673562B2 (en) 2005-06-15 2014-03-18 Callida Genomics, Inc. Using non-overlapping fragments for nucleic acid sequencing
US7901891B2 (en) 2005-06-15 2011-03-08 Callida Genomics, Inc. Nucleic acid analysis by random mixtures of non-overlapping fragments
US9637784B2 (en) 2005-06-15 2017-05-02 Complete Genomics, Inc. Methods for DNA sequencing and analysis using multiple tiers of aliquots
US9637785B2 (en) 2005-06-15 2017-05-02 Complete Genomics, Inc. Tagged fragment library configured for genome or cDNA sequence analysis
US20090137404A1 (en) * 2005-06-15 2009-05-28 Complete Genomics, Inc. Single molecule arrays for genetic and chemical analysis
US8765379B2 (en) 2005-06-15 2014-07-01 Callida Genomics, Inc. Nucleic acid sequence analysis from combined mixtures of amplified fragments
US8445196B2 (en) 2005-06-15 2013-05-21 Callida Genomics, Inc. Single molecule arrays for genetic and chemical analysis
US20090011943A1 (en) * 2005-06-15 2009-01-08 Complete Genomics, Inc. High throughput genome sequencing on DNA arrays
US9650673B2 (en) 2005-06-15 2017-05-16 Complete Genomics, Inc. Single molecule arrays for genetic and chemical analysis
US20070099208A1 (en) * 2005-06-15 2007-05-03 Radoje Drmanac Single molecule arrays for genetic and chemical analysis
US8445197B2 (en) 2005-06-15 2013-05-21 Callida Genomics, Inc. Single molecule arrays for genetic and chemical analysis
US9476054B2 (en) 2005-06-15 2016-10-25 Complete Genomics, Inc. Two-adaptor library for high-throughput sequencing on DNA arrays
US8771957B2 (en) 2005-06-15 2014-07-08 Callida Genomics, Inc. Sequencing using a predetermined coverage amount of polynucleotide fragments
US8771958B2 (en) 2005-06-15 2014-07-08 Callida Genomics, Inc. Nucleotide sequence from amplicon subfragments
US20110071053A1 (en) * 2005-06-15 2011-03-24 Callida Genomics, Inc. Single Molecule Arrays for Genetic and Chemical Analysis
US8765375B2 (en) 2005-06-15 2014-07-01 Callida Genomics, Inc. Method for sequencing polynucleotides by forming separate fragment mixtures
US8765382B2 (en) 2005-06-15 2014-07-01 Callida Genomics, Inc. Genome sequence analysis using tagged amplicons
US8133719B2 (en) 2005-06-15 2012-03-13 Callida Genomics, Inc. Methods for making single molecule arrays
US8445194B2 (en) 2005-06-15 2013-05-21 Callida Genomics, Inc. Single molecule arrays for genetic and chemical analysis
US20080038725A1 (en) * 2005-06-20 2008-02-14 Yuling Luo Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
US8604182B2 (en) 2005-06-20 2013-12-10 Advanced Cell Diagnostics, Inc. Multiplex detection of nucleic acids
US20090081688A1 (en) * 2005-06-20 2009-03-26 Advanced Cell Diagnostics Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
US20110059442A1 (en) * 2005-06-20 2011-03-10 Advanced Cell Diagnostics, Inc. Multiplex detection of nucleic acids
US20110059866A1 (en) * 2005-06-20 2011-03-10 Advanced Cell Diagnostics, Inc. Multiplex detection of nucleic acids
US8951726B2 (en) 2005-06-20 2015-02-10 Advanced Cell Diagnostics, Inc. Multiplex detection of nucleic acids
US20100331212A1 (en) * 2005-08-11 2010-12-30 Pacific Bioseciences Of California, Inc. Methods and systems for monitoring multiple optical signals from a single source
US7805081B2 (en) 2005-08-11 2010-09-28 Pacific Biosciences Of California, Inc. Methods and systems for monitoring multiple optical signals from a single source
US20080226307A1 (en) * 2005-08-11 2008-09-18 Pacific Biosciences Of California, Inc. Methods and systems for monitoring multiple optical signals from a single source
US20070036511A1 (en) * 2005-08-11 2007-02-15 Pacific Biosciences Of California, Inc. Methods and systems for monitoring multiple optical signals from a single source
US20070072196A1 (en) * 2005-09-29 2007-03-29 Pacific Biosciences Of California, Inc. Fluorescent nucleotide analogs and uses therefor
US7405281B2 (en) 2005-09-29 2008-07-29 Pacific Biosciences Of California, Inc. Fluorescent nucleotide analogs and uses therefor
US20090018324A1 (en) * 2005-09-29 2009-01-15 Pacific Biosciences Of California, Inc. Labeled nucleotide analogs and uses therefor
US20110059450A1 (en) * 2005-09-29 2011-03-10 Pacific Biosciences Of California, Inc. Labeled nucleotide analogs and uses therefor
US8058031B2 (en) 2005-09-29 2011-11-15 Pacific Biosciences Of California, Inc. Labeled nucleotide analogs and uses therefor
US7777013B2 (en) 2005-09-29 2010-08-17 Pacific Biosciences Of California, Inc. Labeled nucleotide analogs and uses therefor
US8137942B2 (en) 2005-09-30 2012-03-20 Pacific Biosciences Of California, Inc. Method of preparing a modified surface
US20090061429A1 (en) * 2005-09-30 2009-03-05 Pacific Biosciences Of California, Inc Reactive surfaces, substrates and methods of producing and using same
US7763423B2 (en) 2005-09-30 2010-07-27 Pacific Biosciences Of California, Inc. Substrates having low density reactive groups for monitoring enzyme activity
US20090061430A1 (en) * 2005-09-30 2009-03-05 Pacific Biosciences Of California, Inc. Reactive surfaces, substrates and methods of producing and using same
US7993891B2 (en) 2005-09-30 2011-08-09 Pacific Biosciences Of California, Inc. Method for binding reactive groups in observation area of zero mode waveguide
US20100081128A1 (en) * 2005-10-07 2010-04-01 Radoje Drmanac Self-assembled single molecule arrays and uses thereof
US8609335B2 (en) 2005-10-07 2013-12-17 Callida Genomics, Inc. Self-assembled single molecule arrays and uses thereof
US7960104B2 (en) 2005-10-07 2011-06-14 Callida Genomics, Inc. Self-assembled single molecule arrays and uses thereof
US20070161017A1 (en) * 2005-12-02 2007-07-12 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US20070128133A1 (en) * 2005-12-02 2007-06-07 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US8071346B2 (en) 2005-12-02 2011-12-06 Pacific Bioscience Of California, Inc. System for the mitigation of photodamage in analytical reactions
US8415128B2 (en) 2005-12-02 2013-04-09 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US7993895B2 (en) 2005-12-02 2011-08-09 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US20080176241A1 (en) * 2005-12-02 2008-07-24 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US7998717B2 (en) 2005-12-02 2011-08-16 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US20070168197A1 (en) * 2006-01-18 2007-07-19 Nokia Corporation Audio coding
US20070188750A1 (en) * 2006-02-13 2007-08-16 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US7995202B2 (en) 2006-02-13 2011-08-09 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US7961314B2 (en) 2006-02-13 2011-06-14 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US20080157005A1 (en) * 2006-02-13 2008-07-03 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US20080212960A1 (en) * 2006-02-13 2008-09-04 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US20080165346A1 (en) * 2006-02-13 2008-07-10 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US7630073B2 (en) 2006-02-13 2009-12-08 Pacific Biosciences Of California Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US8149399B2 (en) 2006-02-13 2012-04-03 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US7692783B2 (en) 2006-02-13 2010-04-06 Pacific Biosciences Of California Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US7626704B2 (en) 2006-02-13 2009-12-01 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US8264687B2 (en) 2006-02-13 2012-09-11 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US7715001B2 (en) 2006-02-13 2010-05-11 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US20070206187A1 (en) * 2006-02-13 2007-09-06 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US20080030628A1 (en) * 2006-02-13 2008-02-07 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
US20090155781A1 (en) * 2006-02-24 2009-06-18 Complete Genomics, Inc. High throughput genome sequencing on DNA arrays
US20090118488A1 (en) * 2006-02-24 2009-05-07 Complete Genomics, Inc. High throughput genome sequencing on DNA arrays
US8440397B2 (en) 2006-02-24 2013-05-14 Callida Genomics, Inc. High throughput genome sequencing on DNA arrays
US20090005252A1 (en) * 2006-02-24 2009-01-01 Complete Genomics, Inc. High throughput genome sequencing on DNA arrays
US20090264299A1 (en) * 2006-02-24 2009-10-22 Complete Genomics, Inc. High throughput genome sequencing on DNA arrays
US8722326B2 (en) 2006-02-24 2014-05-13 Callida Genomics, Inc. High throughput genome sequencing on DNA arrays
US8193123B2 (en) 2006-03-30 2012-06-05 Pacific Biosciences Of California, Inc. Articles having localized molecules disposed thereon and methods of producing same
US8975216B2 (en) 2006-03-30 2015-03-10 Pacific Biosciences Of California Articles having localized molecules disposed thereon and methods of producing same
US20080176769A1 (en) * 2006-03-30 2008-07-24 Pacific Biosciences Of California, Inc. Articles having localized molecules disposed thereon and methods of producing same
US20080032301A1 (en) * 2006-03-30 2008-02-07 Pacific Biosciences Of California, Inc. Articles having localized molecules disposed thereon and methods of producing same
US20080153100A1 (en) * 2006-03-30 2008-06-26 Pacific Biosciences Of California, Inc. Articles having localized molecules disposed thereon and methods of producing same
US8772202B2 (en) 2006-03-30 2014-07-08 Pacific Biosciences Of California, Inc. Articles having localized molecules disposed thereon and methods of producing same
US8802600B2 (en) 2006-03-30 2014-08-12 Pacific Biosciences Of California, Inc. Articles having localized molecules disposed thereon and methods of producing same
US20080050747A1 (en) * 2006-03-30 2008-02-28 Pacific Biosciences Of California, Inc. Articles having localized molecules disposed thereon and methods of producing and using same
US7563574B2 (en) 2006-03-31 2009-07-21 Pacific Biosciences Of California, Inc. Methods, systems and compositions for monitoring enzyme activity and applications thereof
US9133504B2 (en) 2006-06-05 2015-09-15 California Institute Of Technology Real time microarrays
US20080039339A1 (en) * 2006-06-05 2008-02-14 Arjang Hassibi Real Time Microarrays
US8048626B2 (en) 2006-07-28 2011-11-01 California Institute Of Technology Multiplex Q-PCR arrays
US20080176757A1 (en) * 2006-07-28 2008-07-24 Arjang Hassibi Multiplex Q-PCR Arrays
US9458497B2 (en) 2006-07-28 2016-10-04 California Institute Of Technology Multiplex Q-PCR arrays
US7834329B2 (en) 2006-09-01 2010-11-16 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US9587276B2 (en) 2006-09-01 2017-03-07 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US8618507B1 (en) 2006-09-01 2013-12-31 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US9222133B2 (en) 2006-09-01 2015-12-29 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US20080152280A1 (en) * 2006-09-01 2008-06-26 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US20100065726A1 (en) * 2006-09-01 2010-03-18 Pacific Biosciences Of California, Inc. Substrates and optical systems and methods of use thereof
US7838847B2 (en) 2006-09-01 2010-11-23 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US20080152281A1 (en) * 2006-09-01 2008-06-26 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US8471219B2 (en) 2006-09-01 2013-06-25 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US8471230B2 (en) 2006-09-01 2013-06-25 Pacific Biosciences Of California, Inc. Waveguide substrates and optical systems and methods of use thereof
US20080128627A1 (en) * 2006-09-01 2008-06-05 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US8053742B2 (en) 2006-09-01 2011-11-08 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US20110082051A1 (en) * 2006-09-01 2011-04-07 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US7820983B2 (en) 2006-09-01 2010-10-26 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US9029802B2 (en) 2006-09-01 2015-05-12 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US8207509B2 (en) 2006-09-01 2012-06-26 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US20080080059A1 (en) * 2006-09-28 2008-04-03 Pacific Biosciences Of California, Inc. Modular optical components and systems incorporating same
US7910354B2 (en) 2006-10-27 2011-03-22 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
US20080318796A1 (en) * 2006-10-27 2008-12-25 Complete Genomics,Inc. Efficient arrays of amplified polynucleotides
US7910302B2 (en) 2006-10-27 2011-03-22 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
US9228228B2 (en) 2006-10-27 2016-01-05 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
US20090143235A1 (en) * 2006-10-27 2009-06-04 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
US20080221832A1 (en) * 2006-11-09 2008-09-11 Complete Genomics, Inc. Methods for computing positional base probabilities using experminentals base value distributions
US20080171331A1 (en) * 2006-11-09 2008-07-17 Complete Genomics, Inc. Methods and Compositions for Large-Scale Analysis of Nucleic Acids Using DNA Deletions
US9334490B2 (en) 2006-11-09 2016-05-10 Complete Genomics, Inc. Methods and compositions for large-scale analysis of nucleic acids using DNA deletions
US20080237021A1 (en) * 2007-03-30 2008-10-02 Intermec Technologies Corporation Keypad overlay membrane
US20100167413A1 (en) * 2007-05-10 2010-07-01 Paul Lundquist Methods and systems for analyzing fluorescent materials with reduced autofluorescence
US20080277595A1 (en) * 2007-05-10 2008-11-13 Pacific Biosciences Of California, Inc. Highly multiplexed confocal detection systems and methods of using same
US8951731B2 (en) 2007-10-15 2015-02-10 Complete Genomics, Inc. Sequence analysis using decorated nucleic acids
US20090111115A1 (en) * 2007-10-15 2009-04-30 Complete Genomics, Inc. Sequence analysis using decorated nucleic acids
US8518640B2 (en) 2007-10-29 2013-08-27 Complete Genomics, Inc. Nucleic acid sequencing and process
US20100105052A1 (en) * 2007-10-29 2010-04-29 Complete Genomics, Inc. Nucleic acid sequencing and process
US7901890B2 (en) 2007-11-05 2011-03-08 Complete Genomics, Inc. Methods and oligonucleotide designs for insertion of multiple adaptors employing selective methylation
US20090203551A1 (en) * 2007-11-05 2009-08-13 Complete Genomics, Inc. Methods and Oligonucleotide Designs for Insertion of Multiple Adaptors Employing Selective Methylation
US8551702B2 (en) 2007-11-05 2013-10-08 Complete Genomics, Inc. Efficient base determination in sequencing reactions
US8415099B2 (en) 2007-11-05 2013-04-09 Complete Genomics, Inc. Efficient base determination in sequencing reactions
US20090176234A1 (en) * 2007-11-05 2009-07-09 Complete Genomics, Inc. Efficient base determination in sequencing reactions
US9267172B2 (en) 2007-11-05 2016-02-23 Complete Genomics, Inc. Efficient base determination in sequencing reactions
US7897344B2 (en) 2007-11-06 2011-03-01 Complete Genomics, Inc. Methods and oligonucleotide designs for insertion of multiple adaptors into library constructs
US20090176652A1 (en) * 2007-11-06 2009-07-09 Complete Genomics, Inc. Methods and Oligonucleotide Designs for Insertion of Multiple Adaptors into Library Constructs
US8298768B2 (en) 2007-11-29 2012-10-30 Complete Genomics, Inc. Efficient shotgun sequencing methods
US20090318304A1 (en) * 2007-11-29 2009-12-24 Complete Genomics, Inc. Efficient Shotgun Sequencing Methods
US9238834B2 (en) 2007-11-29 2016-01-19 Complete Genomics, Inc. Efficient shotgun sequencing methods
US8592150B2 (en) 2007-12-05 2013-11-26 Complete Genomics, Inc. Methods and compositions for long fragment read sequencing
US9499863B2 (en) 2007-12-05 2016-11-22 Complete Genomics, Inc. Reducing GC bias in DNA sequencing using nucleotide analogs
US9523125B2 (en) 2008-01-28 2016-12-20 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US9222132B2 (en) 2008-01-28 2015-12-29 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US8617811B2 (en) 2008-01-28 2013-12-31 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US20090263802A1 (en) * 2008-01-28 2009-10-22 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US20090270273A1 (en) * 2008-04-21 2009-10-29 Complete Genomics, Inc. Array structures for nucleic acid detection
US9719138B2 (en) 2008-09-16 2017-08-01 Pacific Biosciences Of California, Inc. Substrates and optical systems and methods of use thereof having a single optically resolvable immobilized reaction component disposed within a nanometer-scale aperture
US9222123B2 (en) 2008-09-16 2015-12-29 Pacific Biosciences Of California, Inc. Analytic devices comprising optical waveguides and nanometer-scale apertures and methods of uses thereof
US8274040B2 (en) 2008-09-16 2012-09-25 Pacific Biosciences Of California, Inc. Substrates and optical system having at least one optical waveguide, at least one nanometer-scale aperture and at least one lens array and methods of use thereof
US9524369B2 (en) 2009-06-15 2016-12-20 Complete Genomics, Inc. Processing and analysis of complex nucleic acid sequence data
US8501406B1 (en) 2009-07-14 2013-08-06 Pacific Biosciences Of California, Inc. Selectively functionalized arrays
US8834847B2 (en) 2010-08-12 2014-09-16 Pacific Biosciences Of California, Inc. Photodamage mitigation compounds and systems
US9732382B2 (en) 2010-08-12 2017-08-15 Pacific Biosciences Of California, Inc. Photodamage mitigation compounds and systems
US9739773B1 (en) 2010-08-13 2017-08-22 David Gordon Bermudes Compositions and methods for determining successful immunization by one or more vaccines
US8778614B2 (en) 2010-08-24 2014-07-15 Enzo Life Sciences, Inc. Assays for detecting modified compounds
WO2012027195A1 (en) 2010-08-24 2012-03-01 Enzo Biochem, Inc. Assays for detecting modified compounds
US9404143B2 (en) 2010-08-24 2016-08-02 Enzo Life Sciences, Inc. Assays for detecting modified compounds
US9315854B2 (en) 2010-10-21 2016-04-19 Advanced Cell Diagnostics, Inc. Ultra sensitive method for in situ detection of nucleic acids
US8658361B2 (en) 2010-10-21 2014-02-25 Advanced Cell Diagnostics, Inc. Ultra sensitive method for in situ detection of nucleic acids
US9890411B2 (en) 2011-02-16 2018-02-13 Waters Technologies Corporation Immobilized enzymatic reactor
US9833761B2 (en) 2013-08-05 2017-12-05 Twist Bioscience Corporation De novo synthesized gene libraries
US9895673B2 (en) 2015-12-01 2018-02-20 Twist Bioscience Corporation Functionalized surfaces and preparation thereof

Also Published As

Publication number Publication date Type
US4994373A (en) 1991-02-19 grant

Similar Documents

Publication Publication Date Title
US5279935A (en) Method of immunossay including deactivation of endogenous alkaline phosphatase
US4898951A (en) Compounds used as intermediates in the preparations of non-radioactive biological probes
US5210015A (en) Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5527673A (en) Apparatus and method for transport of nucleic acid sequences by capillary action on a solid support and detection of the nucleic acid sequences
US6238866B1 (en) Detector for nucleic acid typing and methods of using the same
Beck et al. Chemiluminescent detection of DNA: application for DNA sequencing and hybridization
US6316186B1 (en) Binding assay using binding agents with tail groups
EP0478319B1 (en) Gene detection method
US5667976A (en) Solid supports for nucleic acid hybridization assays
US5843650A (en) Nucleic acid detection and amplification by chemical linkage of oligonucleotides
US5683875A (en) Method for detecting a target nucleic acid analyte in a sample
US5232829A (en) Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes
US5200313A (en) Nucleic acid hybridization assay employing detectable anti-hybrid antibodies
US4751177A (en) Methods and kits for performing nucleic acid hybridization assays
US4824775A (en) Cells labeled with multiple Fluorophores bound to a nucleic acid carrier
US4497899A (en) Immunoassay for Chlamydia trachomatis antigens
US4987065A (en) In vivo labelling of polynucleotide sequences
US5543292A (en) Process for the measurement of nucleic acids
US5104791A (en) Particle counting nucleic acid hybridization assays
US5656731A (en) Nucleic acid-amplified immunoassay probes
Lai [26] Detection of peptides by fluorescence methods
US5514785A (en) Solid supports for nucleic acid hybridization assays
US6468751B1 (en) Method and apparatus for performing amplification of nucleic acid on supports
US5385824A (en) Method for detection of anti-RNA-antibodies
US4978614A (en) Method of detecting a substance using enzymatically-induced decomposition of dioxetanes

Legal Events

Date Code Title Description
AS Assignment

Owner name: ENZO LIFE SCIENCES, INC., NEW YORK

Free format text: CHANGE OF NAME;ASSIGNOR:ENZO DIAGNOSTICS, INC.;REEL/FRAME:017133/0718

Effective date: 20011221

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

IPR Aia trial proceeding filed before the patent and appeal board: inter partes review

Free format text: TRIAL NO: IPR2016-00822

Opponent name: HOLOGIC, INC. ANDGEN-PROBE INCORPORATED

Effective date: 20160330

Free format text: TRIAL NO: IPR2016-00820

Opponent name: HOLOGIC, INC. ANDGEN-PROBE INCORPORATED

Effective date: 20160330

IPR Aia trial proceeding filed before the patent and appeal board: inter partes review

Free format text: TRIAL NO: IPR2017-00181

Opponent name: BECTON, DICKINSON AND COMPANY

Effective date: 20161103

Free format text: TRIAL NO: IPR2017-00172

Opponent name: BECTON, DICKINSON ANDCOMPANY

Effective date: 20161103

FPAY Fee payment

Year of fee payment: 12